Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSMUSG00000005677.8 | nuclear receptor subfamily 1, group I, member 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_171214229_171214409 | Nr1i3 | 30 | 0.937023 | 0.59 | 2.1e-06 | Click! |
chr1_171213770_171214052 | Nr1i3 | 59 | 0.930774 | 0.56 | 8.4e-06 | Click! |
chr1_171212903_171213054 | Nr1i3 | 992 | 0.298341 | 0.43 | 1.1e-03 | Click! |
chr1_171216756_171216907 | Nr1i3 | 2482 | 0.115435 | 0.22 | 1.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 119.55 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr14_14354416_14355184 | 46.12 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr10_127508848_127510720 | 39.13 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr14_32146198_32146521 | 27.39 |
Msmb |
beta-microseminoprotein |
1228 |
0.33 |
chr4_11147788_11148157 | 25.34 |
Gm11830 |
predicted gene 11830 |
3262 |
0.15 |
chr19_53080891_53081464 | 24.57 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chrY_90771840_90772811 | 24.03 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr5_140647773_140649317 | 23.13 |
Ttyh3 |
tweety family member 3 |
452 |
0.77 |
chr6_52163698_52164573 | 22.53 |
Hoxa2 |
homeobox A2 |
696 |
0.33 |
chr2_156295780_156296095 | 22.24 |
Phf20 |
PHD finger protein 20 |
92 |
0.94 |
chr18_70553238_70553587 | 20.34 |
Mbd2 |
methyl-CpG binding domain protein 2 |
14777 |
0.16 |
chr2_158305932_158306715 | 20.23 |
Lbp |
lipopolysaccharide binding protein |
170 |
0.92 |
chrX_169997850_169998483 | 19.89 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chr5_112001700_112002600 | 19.84 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr5_124091870_124092203 | 19.81 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
1774 |
0.21 |
chr12_80103423_80104027 | 19.71 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
9269 |
0.12 |
chr14_27072004_27072346 | 19.66 |
Il17rd |
interleukin 17 receptor D |
4778 |
0.24 |
chr5_66052662_66053184 | 19.42 |
Rbm47 |
RNA binding motif protein 47 |
1629 |
0.27 |
chr12_72535708_72536908 | 19.14 |
Pcnx4 |
pecanex homolog 4 |
75 |
0.97 |
chr10_99268740_99269700 | 18.83 |
Gm34921 |
predicted gene, 34921 |
1226 |
0.27 |
chr1_86525613_86527056 | 18.81 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr3_144198270_144199266 | 18.74 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr7_16046417_16047443 | 18.32 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr9_43264214_43264450 | 18.25 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
131 |
0.96 |
chr11_54860143_54861186 | 18.22 |
Lyrm7 |
LYR motif containing 7 |
55 |
0.96 |
chr2_119166896_119167867 | 17.92 |
Gchfr |
GTP cyclohydrolase I feedback regulator |
392 |
0.73 |
chr1_168287679_168288893 | 17.81 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr8_125910003_125910420 | 17.64 |
Map3k21 |
mitogen-activated protein kinase kinase kinase 21 |
239 |
0.92 |
chr2_121036499_121036885 | 17.63 |
Epb42 |
erythrocyte membrane protein band 4.2 |
11 |
0.96 |
chr5_109557850_109558797 | 17.58 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr1_86501052_86501969 | 17.57 |
Ptma |
prothymosin alpha |
25216 |
0.11 |
chr11_74896307_74898160 | 17.52 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr11_102375203_102375512 | 17.42 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
1663 |
0.21 |
chr4_140854328_140855106 | 17.31 |
Padi1 |
peptidyl arginine deiminase, type I |
8939 |
0.13 |
chr14_14353319_14353777 | 17.18 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr18_35848127_35849279 | 17.13 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr12_13218119_13218632 | 17.08 |
Ddx1 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 |
11004 |
0.19 |
chr7_103865311_103865713 | 17.05 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12296 |
0.06 |
chr19_6969291_6970359 | 16.88 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr1_185469823_185470016 | 16.84 |
Gm2061 |
predicted gene 2061 |
14351 |
0.12 |
chr6_84640633_84641008 | 16.83 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
46912 |
0.17 |
chr8_11473087_11473664 | 16.79 |
E230013L22Rik |
RIKEN cDNA E230013L22 gene |
4554 |
0.13 |
chr8_109865208_109865726 | 16.57 |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
2359 |
0.17 |
chr15_9114613_9115328 | 16.48 |
Nadk2 |
NAD kinase 2, mitochondrial |
11982 |
0.18 |
chr5_137530580_137532081 | 16.45 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr3_65658208_65659857 | 16.34 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr1_181257261_181257857 | 16.27 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15239 |
0.14 |
chr3_127930366_127930648 | 16.25 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14335 |
0.14 |
chr18_60605971_60606545 | 16.02 |
Synpo |
synaptopodin |
3847 |
0.19 |
chr13_96698181_96698347 | 15.96 |
Gm48575 |
predicted gene, 48575 |
20141 |
0.14 |
chr7_103826228_103826489 | 15.83 |
Hbb-bs |
hemoglobin, beta adult s chain |
1367 |
0.17 |
chr7_135521666_135522037 | 15.80 |
Clrn3 |
clarin 3 |
6803 |
0.18 |
chr5_119337927_119338125 | 15.79 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
40781 |
0.19 |
chr7_142574309_142575453 | 15.79 |
H19 |
H19, imprinted maternally expressed transcript |
1657 |
0.21 |
chr3_104674273_104674621 | 15.68 |
Gm29560 |
predicted gene 29560 |
4437 |
0.11 |
chr4_132428123_132428546 | 15.68 |
Phactr4 |
phosphatase and actin regulator 4 |
5845 |
0.1 |
chr2_38511311_38512619 | 15.53 |
Nek6 |
NIMA (never in mitosis gene a)-related expressed kinase 6 |
151 |
0.93 |
chr4_133569802_133569961 | 15.49 |
Gpatch3 |
G patch domain containing 3 |
4864 |
0.11 |
chr16_17345888_17346201 | 15.45 |
Gm24927 |
predicted gene, 24927 |
4032 |
0.14 |
chr19_45016824_45017769 | 15.31 |
Lzts2 |
leucine zipper, putative tumor suppressor 2 |
799 |
0.44 |
chr17_34898151_34899707 | 15.31 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr15_82184037_82184673 | 15.30 |
Gm49502 |
predicted gene, 49502 |
1161 |
0.29 |
chr10_75565842_75566317 | 15.21 |
Ggt1 |
gamma-glutamyltransferase 1 |
214 |
0.88 |
chr4_132075006_132075723 | 15.14 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr7_110891747_110891926 | 15.08 |
Gm16336 |
predicted gene 16336 |
13149 |
0.15 |
chr6_125095392_125097556 | 15.02 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr4_140636561_140636849 | 14.92 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
12045 |
0.16 |
chr9_121426081_121426568 | 14.89 |
Trak1 |
trafficking protein, kinesin binding 1 |
10349 |
0.19 |
chr13_84515013_84515539 | 14.88 |
Gm26927 |
predicted gene, 26927 |
175163 |
0.03 |
chr3_100429876_100430192 | 14.85 |
4930406D18Rik |
RIKEN cDNA 4930406D18 gene |
3595 |
0.18 |
chr1_191846706_191847003 | 14.85 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
19706 |
0.13 |
chr3_31260547_31261201 | 14.82 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
2480 |
0.32 |
chr5_151413655_151413971 | 14.77 |
1700028E10Rik |
RIKEN cDNA 1700028E10 gene |
7287 |
0.17 |
chr3_21986580_21986771 | 14.77 |
Gm43674 |
predicted gene 43674 |
11793 |
0.21 |
chr4_123286418_123286738 | 14.73 |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
3483 |
0.12 |
chr11_4094091_4094832 | 14.66 |
Mtfp1 |
mitochondrial fission process 1 |
679 |
0.5 |
chr11_117204633_117204995 | 14.61 |
Septin9 |
septin 9 |
5153 |
0.19 |
chr11_53794666_53795169 | 14.61 |
Gm12216 |
predicted gene 12216 |
958 |
0.43 |
chr7_25895283_25895434 | 14.59 |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
2262 |
0.18 |
chr15_7167953_7168132 | 14.56 |
Lifr |
LIF receptor alpha |
13689 |
0.25 |
chr8_90907824_90909226 | 14.52 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
89 |
0.52 |
chr5_100566956_100567158 | 14.38 |
Plac8 |
placenta-specific 8 |
3634 |
0.17 |
chr5_90510093_90510743 | 14.37 |
Afp |
alpha fetoprotein |
2987 |
0.17 |
chr9_65070584_65070992 | 14.31 |
Dpp8 |
dipeptidylpeptidase 8 |
4215 |
0.17 |
chr19_7240431_7241403 | 14.24 |
Naa40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
117 |
0.93 |
chr7_46830127_46830360 | 14.22 |
Gm45308 |
predicted gene 45308 |
2221 |
0.15 |
chr1_190106720_190107128 | 14.16 |
Gm28172 |
predicted gene 28172 |
61746 |
0.11 |
chr13_35678066_35678217 | 14.14 |
Gm22126 |
predicted gene, 22126 |
16006 |
0.16 |
chr16_32487534_32487848 | 14.13 |
Slc51a |
solute carrier family 51, alpha subunit |
12 |
0.96 |
chr8_105164287_105164924 | 14.10 |
Gm3830 |
predicted gene 3830 |
18 |
0.95 |
chr14_65873411_65873642 | 14.08 |
Ccdc25 |
coiled-coil domain containing 25 |
36166 |
0.13 |
chr14_76569060_76569969 | 13.99 |
Serp2 |
stress-associated endoplasmic reticulum protein family member 2 |
12625 |
0.2 |
chr7_101064633_101064988 | 13.95 |
Gm5735 |
predicted gene 5735 |
3335 |
0.2 |
chr8_94363976_94364322 | 13.83 |
Slc12a3 |
solute carrier family 12, member 3 |
7838 |
0.1 |
chr11_69947320_69948107 | 13.82 |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
261 |
0.73 |
chr11_98922365_98923607 | 13.75 |
Cdc6 |
cell division cycle 6 |
2520 |
0.16 |
chr5_86910820_86911040 | 13.74 |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
3993 |
0.12 |
chr7_103915374_103915666 | 13.74 |
Olfr65 |
olfactory receptor 65 |
9178 |
0.06 |
chr2_128174330_128174481 | 13.71 |
Gm14009 |
predicted gene 14009 |
15582 |
0.2 |
chr7_142570403_142571198 | 13.68 |
H19 |
H19, imprinted maternally expressed transcript |
5738 |
0.11 |
chr7_127672339_127672529 | 13.61 |
Gm44760 |
predicted gene 44760 |
14200 |
0.08 |
chr17_25127091_25127504 | 13.60 |
Clcn7 |
chloride channel, voltage-sensitive 7 |
6094 |
0.1 |
chr15_88919405_88919749 | 13.56 |
Ttll8 |
tubulin tyrosine ligase-like family, member 8 |
291 |
0.87 |
chr4_108066710_108066871 | 13.56 |
Scp2 |
sterol carrier protein 2, liver |
4573 |
0.16 |
chr14_69321815_69322332 | 13.52 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr14_69540059_69540582 | 13.52 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr9_63757305_63758776 | 13.51 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr5_114922913_114923574 | 13.48 |
Oasl1 |
2'-5' oligoadenylate synthetase-like 1 |
3 |
0.5 |
chr7_128289110_128289522 | 13.43 |
BC017158 |
cDNA sequence BC017158 |
611 |
0.44 |
chr12_111517590_111517859 | 13.42 |
Gm40578 |
predicted gene, 40578 |
16884 |
0.1 |
chr18_68230014_68230186 | 13.41 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
2033 |
0.32 |
chr14_116946057_116946269 | 13.33 |
Gpc6 |
glypican 6 |
20227 |
0.3 |
chr6_148513212_148513612 | 13.33 |
Tmtc1 |
transmembrane and tetratricopeptide repeat containing 1 |
69023 |
0.09 |
chr1_80408527_80409167 | 13.32 |
Gm6189 |
predicted gene 6189 |
23662 |
0.13 |
chr11_111687690_111688154 | 13.29 |
Gm11677 |
predicted gene 11677 |
37702 |
0.2 |
chr16_6095931_6096099 | 13.29 |
1700123O21Rik |
RIKEN cDNA 1700123O21 gene |
120430 |
0.07 |
chr5_137349031_137350198 | 13.27 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr11_32297334_32297674 | 13.26 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
876 |
0.41 |
chr11_121543239_121543804 | 13.22 |
Tbcd |
tubulin-specific chaperone d |
680 |
0.7 |
chr1_105088844_105089211 | 13.20 |
Gm29012 |
predicted gene 29012 |
27427 |
0.23 |
chr11_75462325_75462847 | 13.19 |
Tlcd2 |
TLC domain containing 2 |
871 |
0.25 |
chr4_130662932_130663461 | 13.17 |
Pum1 |
pumilio RNA-binding family member 1 |
125 |
0.97 |
chr6_134703019_134703308 | 13.10 |
Borcs5 |
BLOC-1 related complex subunit 5 |
1613 |
0.3 |
chr7_17059591_17061170 | 13.09 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr11_84442587_84442829 | 13.06 |
Aatf |
apoptosis antagonizing transcription factor |
6825 |
0.26 |
chr5_91292941_91293393 | 13.05 |
Gm19619 |
predicted gene, 19619 |
9746 |
0.24 |
chr5_135108172_135108560 | 13.01 |
Mlxipl |
MLX interacting protein-like |
1448 |
0.24 |
chr5_9160958_9162244 | 12.99 |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
70 |
0.97 |
chr1_105885678_105885836 | 12.99 |
Gm37779 |
predicted gene, 37779 |
5255 |
0.21 |
chr9_70926847_70927150 | 12.96 |
Gm32017 |
predicted gene, 32017 |
3490 |
0.25 |
chr11_87729251_87729412 | 12.95 |
Rnf43 |
ring finger protein 43 |
43 |
0.95 |
chr2_119605771_119605947 | 12.93 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
11556 |
0.1 |
chr1_88284232_88284753 | 12.93 |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
6831 |
0.12 |
chr2_155604522_155604830 | 12.92 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6536 |
0.08 |
chr2_25095362_25095586 | 12.91 |
Noxa1 |
NADPH oxidase activator 1 |
325 |
0.75 |
chr11_120353462_120354038 | 12.88 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
5072 |
0.09 |
chr1_130822001_130822203 | 12.88 |
Gm15848 |
predicted gene 15848 |
1398 |
0.29 |
chr5_100632845_100633119 | 12.88 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
31437 |
0.11 |
chr4_145034488_145034899 | 12.85 |
Vps13d |
vacuolar protein sorting 13D |
16341 |
0.23 |
chr9_65826224_65827697 | 12.77 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr2_26139656_26141133 | 12.74 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr9_64044981_64045602 | 12.60 |
Gm25606 |
predicted gene, 25606 |
3205 |
0.17 |
chr11_48855844_48857180 | 12.60 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr11_97435561_97436362 | 12.60 |
Arhgap23 |
Rho GTPase activating protein 23 |
324 |
0.87 |
chr5_144370939_144371340 | 12.57 |
Dmrt1i |
Dmrt1 interacting ncRNA |
12614 |
0.16 |
chr7_101616527_101616725 | 12.53 |
Art2b |
ADP-ribosyltransferase 2b |
31026 |
0.12 |
chr17_56643312_56643463 | 12.52 |
Catsperd |
cation channel sperm associated auxiliary subunit delta |
8395 |
0.1 |
chr2_172901314_172901694 | 12.52 |
Gm22773 |
predicted gene, 22773 |
37163 |
0.14 |
chr5_108674685_108675069 | 12.50 |
Slc26a1 |
solute carrier family 26 (sulfate transporter), member 1 |
92 |
0.94 |
chr2_156296379_156296596 | 12.47 |
Phf20 |
PHD finger protein 20 |
82 |
0.94 |
chr7_114768914_114769312 | 12.45 |
Insc |
INSC spindle orientation adaptor protein |
339 |
0.88 |
chr2_167416107_167416468 | 12.42 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
5425 |
0.2 |
chr7_70358895_70359853 | 12.42 |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
521 |
0.68 |
chr12_79272716_79273016 | 12.39 |
Zfyve26 |
zinc finger, FYVE domain containing 26 |
4453 |
0.2 |
chr4_45513877_45514278 | 12.38 |
Gm22518 |
predicted gene, 22518 |
13525 |
0.14 |
chr2_12923602_12924559 | 12.35 |
Pter |
phosphotriesterase related |
11 |
0.98 |
chr9_3328190_3328384 | 12.34 |
Alkbh8 |
alkB homolog 8, tRNA methyltransferase |
6853 |
0.19 |
chr4_149893565_149894204 | 12.33 |
Gm13070 |
predicted gene 13070 |
10122 |
0.15 |
chr4_134759700_134760317 | 12.30 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
8016 |
0.2 |
chr15_100679042_100679366 | 12.30 |
Cela1 |
chymotrypsin-like elastase family, member 1 |
138 |
0.92 |
chr4_59471420_59471580 | 12.30 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
14272 |
0.18 |
chr6_127321540_127321865 | 12.23 |
Gm43636 |
predicted gene 43636 |
3361 |
0.16 |
chr1_170622997_170623376 | 12.21 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr16_34047647_34047931 | 12.20 |
Kalrn |
kalirin, RhoGEF kinase |
31295 |
0.17 |
chr11_87763473_87764852 | 12.15 |
Tspoap1 |
TSPO associated protein 1 |
569 |
0.56 |
chr4_136175862_136176608 | 12.15 |
E2f2 |
E2F transcription factor 2 |
3841 |
0.17 |
chr8_70193232_70193519 | 12.14 |
Tmem161a |
transmembrane protein 161A |
12836 |
0.09 |
chr15_99724323_99725930 | 12.13 |
Cox14 |
cytochrome c oxidase assembly protein 14 |
521 |
0.41 |
chr13_104636008_104636486 | 12.12 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
48684 |
0.17 |
chr5_141852252_141852469 | 12.12 |
Sdk1 |
sidekick cell adhesion molecule 1 |
4427 |
0.36 |
chr2_173152672_173153088 | 12.11 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
168 |
0.95 |
chr6_38911263_38911582 | 12.11 |
Tbxas1 |
thromboxane A synthase 1, platelet |
7558 |
0.21 |
chr4_145000143_145000472 | 12.08 |
Vps13d |
vacuolar protein sorting 13D |
16346 |
0.21 |
chr9_78229856_78230020 | 12.07 |
Gsta1 |
glutathione S-transferase, alpha 1 (Ya) |
718 |
0.49 |
chr8_123181510_123181661 | 12.01 |
Dpep1 |
dipeptidase 1 |
4657 |
0.08 |
chr1_119541086_119541484 | 12.01 |
3830432H09Rik |
RIKEN cDNA 3830432H09 gene |
5120 |
0.13 |
chr8_46408961_46409130 | 11.99 |
Gm45253 |
predicted gene 45253 |
23157 |
0.13 |
chr7_126271797_126273090 | 11.99 |
Sbk1 |
SH3-binding kinase 1 |
176 |
0.92 |
chr4_108024873_108025051 | 11.98 |
Podn |
podocan |
647 |
0.62 |
chr19_46849013_46849186 | 11.98 |
Cnnm2 |
cyclin M2 |
16561 |
0.17 |
chr15_88875576_88876323 | 11.97 |
Pim3 |
proviral integration site 3 |
11029 |
0.13 |
chr3_127929993_127930179 | 11.97 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
13914 |
0.14 |
chr7_28053430_28053913 | 11.96 |
Gm44744 |
predicted gene 44744 |
1061 |
0.37 |
chr12_79557815_79558259 | 11.94 |
Rad51b |
RAD51 paralog B |
230684 |
0.02 |
chr9_103007679_103008651 | 11.93 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
11 |
0.97 |
chr4_134506347_134506530 | 11.93 |
Aunip |
aurora kinase A and ninein interacting protein |
4561 |
0.12 |
chr10_128525093_128526268 | 11.93 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr9_70940266_70940434 | 11.93 |
Lipc |
lipase, hepatic |
5542 |
0.22 |
chr1_84963483_84964351 | 11.92 |
AC167036.1 |
novel protein |
4935 |
0.14 |
chr11_78982143_78982376 | 11.90 |
Lgals9 |
lectin, galactose binding, soluble 9 |
2572 |
0.27 |
chr11_115833007_115833489 | 11.89 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
677 |
0.52 |
chr2_155604966_155605247 | 11.87 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6106 |
0.08 |
chr7_14525378_14525601 | 11.86 |
Obox4-ps2 |
oocyte specific homeobox 4, pseudogene 2 |
4577 |
0.13 |
chr11_98941353_98942362 | 11.86 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chr8_123039371_123039840 | 11.85 |
Ankrd11 |
ankyrin repeat domain 11 |
2415 |
0.17 |
chr17_74489622_74490192 | 11.80 |
Yipf4 |
Yip1 domain family, member 4 |
29 |
0.97 |
chr8_120549369_120550473 | 11.79 |
Mir7687 |
microRNA 7687 |
11225 |
0.1 |
chr1_193152702_193153255 | 11.79 |
Irf6 |
interferon regulatory factor 6 |
133 |
0.93 |
chr6_72097140_72098281 | 11.79 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr11_30648868_30649937 | 11.78 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.6 | 37.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
11.3 | 11.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
11.0 | 55.1 | GO:0070627 | ferrous iron import(GO:0070627) |
9.7 | 29.1 | GO:0045472 | response to ether(GO:0045472) |
9.6 | 38.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
8.3 | 25.0 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
8.1 | 24.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
8.1 | 24.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
7.9 | 23.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
7.8 | 31.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
7.8 | 31.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
7.8 | 23.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
7.7 | 15.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
7.7 | 46.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
7.7 | 23.1 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
7.7 | 15.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
7.7 | 23.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
7.6 | 15.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
7.6 | 30.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
7.6 | 15.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
7.5 | 30.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
7.4 | 22.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
7.3 | 14.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
7.3 | 29.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
7.1 | 21.4 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
7.0 | 21.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
6.9 | 20.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
6.9 | 34.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
6.8 | 27.1 | GO:1904673 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
6.7 | 40.4 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
6.7 | 33.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
6.7 | 20.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
6.6 | 19.9 | GO:0046618 | drug export(GO:0046618) |
6.5 | 19.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
6.5 | 19.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
6.4 | 38.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
6.4 | 12.8 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
6.4 | 25.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
6.3 | 18.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
6.3 | 18.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
6.3 | 18.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
6.2 | 24.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
6.2 | 6.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
6.1 | 12.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
6.0 | 36.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
5.9 | 23.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
5.9 | 87.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
5.8 | 23.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
5.7 | 5.7 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
5.7 | 11.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
5.6 | 16.9 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
5.5 | 16.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
5.5 | 11.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
5.5 | 16.4 | GO:0008228 | opsonization(GO:0008228) |
5.4 | 16.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
5.4 | 16.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
5.4 | 10.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
5.4 | 5.4 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
5.4 | 16.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
5.3 | 15.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
5.3 | 15.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
5.2 | 21.0 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
5.2 | 26.2 | GO:1904970 | brush border assembly(GO:1904970) |
5.2 | 41.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
5.1 | 30.6 | GO:0015671 | oxygen transport(GO:0015671) |
5.0 | 15.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
5.0 | 14.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.9 | 14.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
4.9 | 14.8 | GO:0002432 | granuloma formation(GO:0002432) |
4.9 | 14.7 | GO:0000087 | mitotic M phase(GO:0000087) |
4.8 | 24.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
4.8 | 28.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
4.8 | 14.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
4.8 | 9.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
4.8 | 14.3 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
4.8 | 19.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
4.7 | 23.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
4.7 | 14.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
4.7 | 28.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
4.7 | 18.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
4.7 | 18.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
4.6 | 13.9 | GO:0032439 | endosome localization(GO:0032439) |
4.6 | 4.6 | GO:0050904 | diapedesis(GO:0050904) |
4.6 | 119.1 | GO:0048821 | erythrocyte development(GO:0048821) |
4.6 | 13.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
4.6 | 22.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
4.6 | 13.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
4.6 | 4.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
4.5 | 9.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
4.5 | 18.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
4.5 | 31.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
4.5 | 18.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
4.5 | 13.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
4.5 | 22.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
4.5 | 13.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
4.5 | 13.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
4.5 | 13.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
4.4 | 4.4 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
4.4 | 13.2 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
4.4 | 30.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
4.3 | 8.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
4.3 | 12.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
4.3 | 4.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
4.3 | 12.8 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
4.3 | 12.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
4.3 | 8.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
4.2 | 4.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
4.2 | 38.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
4.2 | 8.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
4.2 | 4.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
4.2 | 33.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
4.2 | 37.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
4.2 | 12.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.2 | 12.6 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
4.2 | 12.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
4.1 | 8.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
4.1 | 20.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
4.1 | 8.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
4.1 | 36.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
4.1 | 90.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
4.1 | 4.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
4.1 | 8.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
4.1 | 12.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
4.0 | 8.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
4.0 | 16.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.0 | 16.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
4.0 | 12.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.0 | 16.1 | GO:0019532 | oxalate transport(GO:0019532) |
4.0 | 12.0 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
4.0 | 36.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
4.0 | 11.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
4.0 | 11.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
3.9 | 3.9 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
3.9 | 3.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
3.9 | 11.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
3.9 | 19.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
3.9 | 15.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
3.9 | 11.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.9 | 7.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
3.9 | 19.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
3.9 | 19.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
3.9 | 15.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
3.8 | 3.8 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
3.8 | 7.7 | GO:0015793 | glycerol transport(GO:0015793) |
3.8 | 30.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
3.8 | 15.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
3.8 | 3.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
3.8 | 15.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.7 | 11.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
3.7 | 11.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
3.7 | 14.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.7 | 11.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
3.7 | 11.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
3.7 | 18.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
3.7 | 18.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
3.7 | 11.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.7 | 18.4 | GO:0006116 | NADH oxidation(GO:0006116) |
3.7 | 22.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
3.6 | 18.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
3.6 | 7.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
3.6 | 10.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
3.6 | 14.4 | GO:0019627 | urea metabolic process(GO:0019627) |
3.6 | 18.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
3.6 | 10.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
3.6 | 25.1 | GO:0060613 | fat pad development(GO:0060613) |
3.6 | 14.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
3.6 | 17.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
3.6 | 21.4 | GO:0015871 | choline transport(GO:0015871) |
3.6 | 7.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
3.5 | 10.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
3.5 | 10.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.5 | 21.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
3.5 | 24.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
3.5 | 14.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
3.5 | 3.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
3.5 | 10.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
3.5 | 21.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
3.5 | 3.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
3.5 | 3.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
3.5 | 10.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
3.5 | 10.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
3.5 | 38.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
3.5 | 17.3 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
3.5 | 17.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
3.5 | 10.4 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
3.4 | 10.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
3.4 | 13.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
3.4 | 17.2 | GO:0018904 | ether metabolic process(GO:0018904) |
3.4 | 3.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
3.4 | 10.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
3.4 | 13.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.4 | 16.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
3.4 | 37.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
3.4 | 3.4 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
3.4 | 6.7 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
3.3 | 50.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
3.3 | 10.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
3.3 | 10.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
3.3 | 6.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
3.3 | 36.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
3.3 | 13.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
3.3 | 9.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
3.3 | 3.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
3.3 | 6.5 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
3.3 | 6.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
3.2 | 6.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
3.2 | 90.7 | GO:0014823 | response to activity(GO:0014823) |
3.2 | 6.5 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
3.2 | 9.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
3.2 | 38.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
3.2 | 9.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.2 | 12.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
3.2 | 15.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
3.2 | 28.7 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
3.2 | 6.4 | GO:0006868 | glutamine transport(GO:0006868) |
3.2 | 9.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
3.2 | 9.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
3.2 | 12.7 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
3.2 | 15.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
3.1 | 12.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
3.1 | 3.1 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
3.1 | 21.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
3.1 | 3.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
3.1 | 31.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
3.1 | 9.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
3.1 | 37.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
3.1 | 12.4 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
3.1 | 18.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.1 | 6.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
3.1 | 12.4 | GO:0070836 | caveola assembly(GO:0070836) |
3.1 | 9.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
3.1 | 9.2 | GO:0015886 | heme transport(GO:0015886) |
3.1 | 9.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
3.1 | 9.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
3.0 | 9.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
3.0 | 12.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
3.0 | 3.0 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
3.0 | 9.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
3.0 | 6.0 | GO:0050955 | thermoception(GO:0050955) |
3.0 | 33.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
3.0 | 9.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
3.0 | 9.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
3.0 | 3.0 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
3.0 | 3.0 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
3.0 | 9.0 | GO:0009838 | abscission(GO:0009838) |
3.0 | 3.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
3.0 | 3.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.0 | 12.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
3.0 | 6.0 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
3.0 | 3.0 | GO:0007127 | meiosis I(GO:0007127) |
3.0 | 14.9 | GO:0018101 | protein citrullination(GO:0018101) |
3.0 | 3.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
3.0 | 8.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
3.0 | 5.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
3.0 | 32.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
3.0 | 8.9 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
3.0 | 11.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.9 | 8.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.9 | 2.9 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
2.9 | 14.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.9 | 17.5 | GO:0060242 | contact inhibition(GO:0060242) |
2.9 | 5.8 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
2.9 | 2.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.9 | 5.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.9 | 8.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.9 | 5.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
2.9 | 11.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
2.9 | 17.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.9 | 2.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
2.9 | 8.6 | GO:0048102 | autophagic cell death(GO:0048102) |
2.9 | 8.6 | GO:0003383 | apical constriction(GO:0003383) |
2.8 | 8.5 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
2.8 | 50.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.8 | 28.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.8 | 8.5 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
2.8 | 5.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.8 | 8.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.8 | 5.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.8 | 5.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
2.8 | 8.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.8 | 5.6 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
2.8 | 8.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.8 | 8.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.8 | 2.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
2.8 | 8.3 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
2.8 | 11.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
2.8 | 5.5 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
2.8 | 24.8 | GO:0034063 | stress granule assembly(GO:0034063) |
2.8 | 19.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
2.8 | 5.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
2.7 | 8.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
2.7 | 8.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.7 | 13.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.7 | 2.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
2.7 | 2.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
2.7 | 5.4 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.7 | 5.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.7 | 16.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
2.7 | 8.1 | GO:0008050 | female courtship behavior(GO:0008050) |
2.7 | 10.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.7 | 2.7 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
2.7 | 5.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
2.7 | 5.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.7 | 16.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
2.7 | 8.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
2.7 | 24.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
2.7 | 5.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.7 | 5.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.6 | 7.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
2.6 | 10.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
2.6 | 5.3 | GO:0030242 | pexophagy(GO:0030242) |
2.6 | 18.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
2.6 | 7.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.6 | 13.1 | GO:0072553 | terminal button organization(GO:0072553) |
2.6 | 7.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.6 | 21.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.6 | 2.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
2.6 | 10.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.6 | 15.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
2.6 | 15.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
2.6 | 2.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
2.6 | 5.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
2.6 | 5.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
2.6 | 5.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
2.6 | 7.7 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
2.6 | 12.8 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
2.6 | 15.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
2.6 | 5.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.6 | 5.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
2.6 | 2.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
2.5 | 7.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.5 | 2.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.5 | 15.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.5 | 7.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.5 | 5.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
2.5 | 7.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.5 | 7.5 | GO:0015744 | succinate transport(GO:0015744) |
2.5 | 2.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
2.5 | 20.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.5 | 7.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
2.5 | 20.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
2.5 | 15.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.5 | 7.5 | GO:0015705 | iodide transport(GO:0015705) |
2.5 | 17.4 | GO:0010226 | response to lithium ion(GO:0010226) |
2.5 | 10.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
2.5 | 12.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
2.5 | 2.5 | GO:0002159 | desmosome assembly(GO:0002159) |
2.5 | 29.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.5 | 5.0 | GO:0010159 | specification of organ position(GO:0010159) |
2.5 | 7.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.5 | 9.9 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
2.5 | 7.4 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.5 | 2.5 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
2.4 | 4.9 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
2.4 | 4.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.4 | 12.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
2.4 | 2.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
2.4 | 17.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
2.4 | 14.6 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
2.4 | 4.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.4 | 7.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.4 | 12.1 | GO:0048069 | eye pigmentation(GO:0048069) |
2.4 | 14.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.4 | 4.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.4 | 21.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.4 | 2.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.4 | 14.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.4 | 4.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
2.4 | 26.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
2.4 | 7.2 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
2.4 | 11.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.4 | 2.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
2.4 | 7.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.4 | 11.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
2.4 | 7.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.4 | 7.1 | GO:0040031 | snRNA modification(GO:0040031) |
2.4 | 2.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.4 | 21.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
2.4 | 9.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.3 | 7.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.3 | 2.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.3 | 9.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
2.3 | 4.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.3 | 25.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
2.3 | 14.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
2.3 | 9.3 | GO:0051031 | tRNA transport(GO:0051031) |
2.3 | 9.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
2.3 | 6.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
2.3 | 13.9 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
2.3 | 2.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
2.3 | 9.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
2.3 | 2.3 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
2.3 | 2.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.3 | 4.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
2.3 | 29.7 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
2.3 | 25.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
2.3 | 9.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.3 | 4.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
2.3 | 9.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.3 | 2.3 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
2.3 | 6.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.3 | 6.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.3 | 4.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
2.3 | 27.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
2.3 | 2.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
2.3 | 2.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
2.3 | 6.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.3 | 2.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.3 | 2.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
2.2 | 6.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
2.2 | 9.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
2.2 | 6.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.2 | 2.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.2 | 2.2 | GO:0006573 | valine metabolic process(GO:0006573) |
2.2 | 8.9 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.2 | 13.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.2 | 2.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.2 | 8.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
2.2 | 17.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.2 | 13.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
2.2 | 6.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.2 | 4.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
2.2 | 4.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
2.2 | 6.5 | GO:1902166 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
2.2 | 6.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.2 | 32.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.2 | 19.5 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
2.2 | 21.6 | GO:0043486 | histone exchange(GO:0043486) |
2.2 | 10.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
2.2 | 2.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.2 | 2.2 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
2.2 | 2.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.1 | 4.3 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
2.1 | 10.7 | GO:0009642 | response to light intensity(GO:0009642) |
2.1 | 15.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
2.1 | 51.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
2.1 | 4.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
2.1 | 12.8 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
2.1 | 12.8 | GO:0097421 | liver regeneration(GO:0097421) |
2.1 | 12.8 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
2.1 | 8.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.1 | 4.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
2.1 | 21.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
2.1 | 2.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
2.1 | 10.6 | GO:0097066 | response to thyroid hormone(GO:0097066) |
2.1 | 4.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.1 | 4.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
2.1 | 14.8 | GO:0051255 | spindle midzone assembly(GO:0051255) |
2.1 | 8.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.1 | 4.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
2.1 | 2.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
2.1 | 12.5 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
2.1 | 16.7 | GO:0070269 | pyroptosis(GO:0070269) |
2.1 | 4.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
2.1 | 4.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.1 | 4.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.1 | 4.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
2.1 | 26.9 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
2.1 | 8.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
2.1 | 4.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
2.1 | 8.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.1 | 8.2 | GO:0016264 | gap junction assembly(GO:0016264) |
2.1 | 22.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
2.1 | 6.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.0 | 4.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
2.0 | 10.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
2.0 | 6.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.0 | 8.2 | GO:0007144 | female meiosis I(GO:0007144) |
2.0 | 20.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
2.0 | 2.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
2.0 | 2.0 | GO:0060926 | atrioventricular node development(GO:0003162) cardiac pacemaker cell development(GO:0060926) |
2.0 | 6.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.0 | 2.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
2.0 | 2.0 | GO:0034204 | lipid translocation(GO:0034204) |
2.0 | 2.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.0 | 6.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.0 | 4.1 | GO:1903232 | melanosome assembly(GO:1903232) |
2.0 | 2.0 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
2.0 | 8.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.0 | 28.2 | GO:0051923 | sulfation(GO:0051923) |
2.0 | 16.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.0 | 6.0 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
2.0 | 10.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
2.0 | 12.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.0 | 4.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
2.0 | 12.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
2.0 | 2.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
2.0 | 4.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
2.0 | 7.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
2.0 | 6.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.0 | 9.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.0 | 4.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.0 | 5.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.0 | 5.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
2.0 | 11.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
2.0 | 3.9 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.0 | 7.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
2.0 | 47.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
2.0 | 2.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
2.0 | 2.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
2.0 | 9.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
2.0 | 2.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
2.0 | 3.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
2.0 | 9.8 | GO:0007379 | segment specification(GO:0007379) |
2.0 | 3.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
2.0 | 2.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
1.9 | 3.9 | GO:0003032 | detection of oxygen(GO:0003032) |
1.9 | 3.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.9 | 1.9 | GO:0061724 | lipophagy(GO:0061724) |
1.9 | 5.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.9 | 9.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.9 | 1.9 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
1.9 | 5.8 | GO:0060056 | mammary gland involution(GO:0060056) |
1.9 | 11.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.9 | 5.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.9 | 7.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.9 | 7.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.9 | 1.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.9 | 1.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.9 | 5.8 | GO:0009650 | UV protection(GO:0009650) |
1.9 | 1.9 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
1.9 | 1.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
1.9 | 3.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.9 | 5.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.9 | 17.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.9 | 9.5 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.9 | 22.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.9 | 7.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.9 | 15.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.9 | 1.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.9 | 1.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.9 | 1.9 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
1.9 | 1.9 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
1.9 | 5.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.9 | 5.6 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.9 | 1.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.9 | 1.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.9 | 1.9 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
1.9 | 1.9 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
1.9 | 7.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.8 | 7.4 | GO:0048539 | bone marrow development(GO:0048539) |
1.8 | 3.7 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
1.8 | 7.4 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.8 | 3.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.8 | 11.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.8 | 1.8 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
1.8 | 3.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.8 | 1.8 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.8 | 5.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.8 | 5.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
1.8 | 11.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.8 | 11.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.8 | 34.7 | GO:0006301 | postreplication repair(GO:0006301) |
1.8 | 3.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.8 | 5.5 | GO:0061511 | centriole elongation(GO:0061511) |
1.8 | 16.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.8 | 9.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.8 | 12.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.8 | 7.2 | GO:0042737 | drug catabolic process(GO:0042737) |
1.8 | 3.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.8 | 1.8 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
1.8 | 1.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.8 | 17.9 | GO:0017144 | drug metabolic process(GO:0017144) |
1.8 | 1.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.8 | 21.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.8 | 24.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.8 | 16.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.8 | 15.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.8 | 1.8 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
1.8 | 7.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
1.8 | 19.4 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
1.8 | 5.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.8 | 1.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.8 | 1.8 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.8 | 1.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.8 | 7.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.8 | 17.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.7 | 3.5 | GO:0002215 | defense response to nematode(GO:0002215) |
1.7 | 8.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.7 | 3.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.7 | 1.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.7 | 5.2 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.7 | 8.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.7 | 3.5 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
1.7 | 6.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.7 | 12.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.7 | 3.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.7 | 10.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
1.7 | 1.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.7 | 1.7 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
1.7 | 15.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.7 | 1.7 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.7 | 3.4 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
1.7 | 3.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.7 | 3.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.7 | 8.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.7 | 8.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.7 | 11.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.7 | 1.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.7 | 18.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.7 | 6.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.7 | 1.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
1.7 | 5.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.7 | 10.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
1.7 | 23.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.7 | 10.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
1.7 | 15.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.7 | 1.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.7 | 6.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.7 | 3.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
1.7 | 3.3 | GO:0051775 | response to redox state(GO:0051775) |
1.7 | 6.6 | GO:0046782 | regulation of viral transcription(GO:0046782) |
1.7 | 1.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.7 | 6.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.7 | 5.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.7 | 1.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.6 | 1.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.6 | 8.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.6 | 4.9 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.6 | 3.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.6 | 1.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.6 | 4.9 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.6 | 4.9 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
1.6 | 4.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.6 | 3.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.6 | 4.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.6 | 3.3 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.6 | 4.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.6 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.6 | 1.6 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.6 | 8.1 | GO:0043297 | apical junction assembly(GO:0043297) |
1.6 | 8.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.6 | 4.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.6 | 3.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.6 | 3.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.6 | 3.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.6 | 4.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.6 | 9.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
1.6 | 14.4 | GO:0030575 | nuclear body organization(GO:0030575) |
1.6 | 3.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.6 | 1.6 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
1.6 | 12.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
1.6 | 11.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.6 | 3.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
1.6 | 23.8 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
1.6 | 3.2 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
1.6 | 4.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.6 | 9.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.6 | 17.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.6 | 6.3 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
1.6 | 3.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
1.6 | 6.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.6 | 4.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.6 | 3.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.6 | 4.7 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.6 | 1.6 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
1.6 | 6.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.6 | 9.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
1.6 | 7.8 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
1.6 | 1.6 | GO:0051593 | response to folic acid(GO:0051593) |
1.6 | 7.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.6 | 10.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.6 | 3.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.6 | 6.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
1.6 | 4.7 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
1.6 | 4.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.6 | 4.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.6 | 7.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
1.6 | 3.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.6 | 24.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
1.6 | 1.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.5 | 10.8 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
1.5 | 4.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.5 | 1.5 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
1.5 | 7.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.5 | 6.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.5 | 4.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.5 | 6.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
1.5 | 4.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.5 | 1.5 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.5 | 4.6 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.5 | 24.5 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
1.5 | 3.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
1.5 | 10.7 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
1.5 | 3.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.5 | 12.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
1.5 | 4.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.5 | 4.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
1.5 | 7.6 | GO:0002762 | negative regulation of myeloid leukocyte differentiation(GO:0002762) |
1.5 | 1.5 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.5 | 3.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.5 | 1.5 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.5 | 4.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.5 | 6.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.5 | 3.0 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
1.5 | 3.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
1.5 | 1.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
1.5 | 12.0 | GO:0043248 | proteasome assembly(GO:0043248) |
1.5 | 6.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.5 | 9.0 | GO:0015825 | L-serine transport(GO:0015825) |
1.5 | 7.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.5 | 1.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
1.5 | 1.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.5 | 1.5 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
1.5 | 1.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 3.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.5 | 3.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
1.5 | 13.4 | GO:0070166 | enamel mineralization(GO:0070166) |
1.5 | 7.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.5 | 3.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.5 | 11.8 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
1.5 | 10.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.5 | 3.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.5 | 1.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.5 | 17.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.5 | 2.9 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.5 | 4.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.5 | 5.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.5 | 4.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.5 | 4.4 | GO:0015669 | gas transport(GO:0015669) |
1.5 | 14.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.5 | 23.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.5 | 1.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
1.5 | 8.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.5 | 2.9 | GO:0071865 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
1.5 | 16.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
1.5 | 1.5 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.5 | 5.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.4 | 5.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.4 | 1.4 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
1.4 | 7.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.4 | 17.3 | GO:0045116 | protein neddylation(GO:0045116) |
1.4 | 4.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.4 | 8.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.4 | 2.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.4 | 12.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.4 | 2.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.4 | 1.4 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
1.4 | 1.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.4 | 1.4 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
1.4 | 4.3 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
1.4 | 4.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.4 | 4.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.4 | 8.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.4 | 5.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
1.4 | 1.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.4 | 2.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.4 | 11.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.4 | 5.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.4 | 4.2 | GO:0018343 | protein farnesylation(GO:0018343) |
1.4 | 2.8 | GO:0042148 | strand invasion(GO:0042148) |
1.4 | 2.8 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.4 | 2.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.4 | 7.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.4 | 8.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
1.4 | 5.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.4 | 4.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.4 | 8.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.4 | 1.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.4 | 11.1 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
1.4 | 4.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.4 | 5.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
1.4 | 4.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.4 | 5.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.4 | 2.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.4 | 13.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.4 | 9.6 | GO:0006907 | pinocytosis(GO:0006907) |
1.4 | 6.8 | GO:0060068 | vagina development(GO:0060068) |
1.4 | 1.4 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
1.4 | 9.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.3 | 16.2 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
1.3 | 2.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
1.3 | 6.7 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
1.3 | 2.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.3 | 2.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.3 | 1.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.3 | 1.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.3 | 8.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.3 | 21.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.3 | 8.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.3 | 1.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
1.3 | 2.7 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
1.3 | 4.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.3 | 4.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.3 | 4.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.3 | 1.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.3 | 13.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.3 | 6.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.3 | 7.9 | GO:0006833 | water transport(GO:0006833) |
1.3 | 1.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.3 | 3.9 | GO:0090148 | membrane fission(GO:0090148) |
1.3 | 9.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.3 | 2.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.3 | 5.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.3 | 9.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.3 | 2.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.3 | 5.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.3 | 7.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.3 | 1.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.3 | 2.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.3 | 10.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.3 | 37.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.3 | 2.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.3 | 3.9 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.3 | 2.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.3 | 19.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.3 | 5.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
1.3 | 1.3 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
1.3 | 5.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.3 | 6.4 | GO:0000012 | single strand break repair(GO:0000012) |
1.3 | 1.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
1.3 | 6.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.3 | 1.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.3 | 1.3 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
1.3 | 5.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.3 | 21.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.3 | 2.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.3 | 1.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.3 | 2.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.3 | 26.6 | GO:0006513 | protein monoubiquitination(GO:0006513) |
1.3 | 3.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.3 | 8.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.3 | 2.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.3 | 5.0 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.3 | 1.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.3 | 8.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
1.2 | 3.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.2 | 1.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.2 | 2.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.2 | 3.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.2 | 2.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.2 | 2.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.2 | 5.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.2 | 1.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.2 | 2.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.2 | 1.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
1.2 | 4.9 | GO:0070459 | prolactin secretion(GO:0070459) |
1.2 | 2.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.2 | 6.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.2 | 8.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.2 | 4.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.2 | 11.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.2 | 1.2 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
1.2 | 1.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.2 | 18.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.2 | 7.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.2 | 6.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.2 | 9.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
1.2 | 4.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.2 | 8.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.2 | 3.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.2 | 16.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.2 | 2.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.2 | 3.5 | GO:0015889 | cobalamin transport(GO:0015889) |
1.2 | 3.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.2 | 2.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.2 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
1.2 | 2.4 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.2 | 2.4 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
1.2 | 2.4 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.2 | 5.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.2 | 10.6 | GO:0046051 | UTP metabolic process(GO:0046051) |
1.2 | 8.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.2 | 3.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.2 | 1.2 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
1.2 | 3.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.2 | 1.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.2 | 3.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.2 | 5.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.2 | 3.5 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.2 | 4.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.2 | 3.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.2 | 1.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.2 | 3.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
1.2 | 3.5 | GO:0033572 | transferrin transport(GO:0033572) |
1.2 | 1.2 | GO:0033058 | directional locomotion(GO:0033058) |
1.2 | 1.2 | GO:0007494 | midgut development(GO:0007494) |
1.2 | 1.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
1.2 | 2.3 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.1 | 11.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.1 | 6.9 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
1.1 | 2.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.1 | 3.4 | GO:0090383 | phagosome acidification(GO:0090383) |
1.1 | 8.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
1.1 | 9.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.1 | 1.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
1.1 | 9.1 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
1.1 | 2.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
1.1 | 2.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.1 | 2.3 | GO:0035425 | autocrine signaling(GO:0035425) |
1.1 | 3.4 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.1 | 3.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.1 | 2.3 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.1 | 2.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
1.1 | 1.1 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
1.1 | 7.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.1 | 3.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.1 | 7.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.1 | 2.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.1 | 1.1 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
1.1 | 10.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
1.1 | 3.3 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
1.1 | 3.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.1 | 17.8 | GO:0006953 | acute-phase response(GO:0006953) |
1.1 | 3.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.1 | 1.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.1 | 3.3 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
1.1 | 3.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.1 | 15.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
1.1 | 1.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.1 | 4.4 | GO:0001774 | microglial cell activation(GO:0001774) |
1.1 | 3.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.1 | 3.3 | GO:0033227 | dsRNA transport(GO:0033227) |
1.1 | 7.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.1 | 2.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.1 | 1.1 | GO:0018214 | protein carboxylation(GO:0018214) |
1.1 | 1.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.1 | 1.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.1 | 3.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.1 | 4.3 | GO:0051026 | chiasma assembly(GO:0051026) |
1.1 | 2.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.1 | 29.0 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
1.1 | 3.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.1 | 3.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.1 | 5.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.1 | 1.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
1.1 | 5.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
1.1 | 3.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.1 | 3.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.1 | 2.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.1 | 2.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
1.1 | 7.4 | GO:0030539 | male genitalia development(GO:0030539) |
1.1 | 6.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.1 | 4.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.1 | 1.1 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
1.1 | 7.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.0 | 2.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
1.0 | 9.4 | GO:0050892 | intestinal absorption(GO:0050892) |
1.0 | 5.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
1.0 | 14.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.0 | 3.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.0 | 3.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
1.0 | 2.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.0 | 5.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.0 | 31.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.0 | 17.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
1.0 | 12.4 | GO:0006828 | manganese ion transport(GO:0006828) |
1.0 | 6.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.0 | 4.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.0 | 11.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
1.0 | 9.3 | GO:0048535 | lymph node development(GO:0048535) |
1.0 | 6.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
1.0 | 3.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.0 | 1.0 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
1.0 | 6.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
1.0 | 1.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.0 | 1.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.0 | 2.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.0 | 6.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.0 | 1.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.0 | 1.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) regulation of protein glycosylation in Golgi(GO:0090283) |
1.0 | 4.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.0 | 1.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.0 | 1.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
1.0 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 6.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.0 | 1.0 | GO:1902075 | cellular response to salt(GO:1902075) |
1.0 | 4.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.0 | 10.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.0 | 3.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.0 | 2.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.0 | 2.0 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
1.0 | 2.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.0 | 1.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.0 | 3.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.0 | 1.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.0 | 3.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.0 | 5.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.0 | 2.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.0 | 2.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.0 | 3.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.0 | 2.0 | GO:0051383 | kinetochore organization(GO:0051383) |
1.0 | 6.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.0 | 1.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.0 | 1.0 | GO:0043584 | nose development(GO:0043584) |
1.0 | 4.9 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.0 | 6.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.0 | 1.0 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.0 | 1.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.0 | 1.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.0 | 7.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.0 | 5.8 | GO:0042407 | cristae formation(GO:0042407) |
1.0 | 1.9 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.0 | 1.9 | GO:0044838 | cell quiescence(GO:0044838) |
1.0 | 4.8 | GO:0007141 | male meiosis I(GO:0007141) |
1.0 | 1.9 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
1.0 | 4.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.0 | 5.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.0 | 1.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.0 | 4.8 | GO:0031128 | developmental induction(GO:0031128) |
0.9 | 0.9 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.9 | 4.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.9 | 0.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.9 | 1.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.9 | 0.9 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.9 | 2.8 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.9 | 0.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.9 | 0.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.9 | 3.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.9 | 0.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.9 | 5.6 | GO:0016556 | mRNA modification(GO:0016556) |
0.9 | 15.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.9 | 2.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.9 | 5.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.9 | 2.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.9 | 9.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.9 | 0.9 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.9 | 0.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.9 | 1.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.9 | 2.8 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.9 | 12.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.9 | 2.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.9 | 0.9 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.9 | 5.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.9 | 0.9 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.9 | 12.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.9 | 22.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.9 | 4.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.9 | 3.6 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.9 | 0.9 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.9 | 2.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.9 | 17.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.9 | 0.9 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.9 | 3.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.9 | 4.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.9 | 12.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.9 | 2.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.9 | 15.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.9 | 2.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.9 | 0.9 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.9 | 1.8 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.9 | 10.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.9 | 3.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.9 | 4.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.9 | 3.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.9 | 4.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.9 | 0.9 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) positive regulation of tooth mineralization(GO:0070172) |
0.9 | 0.9 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.9 | 1.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 7.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.9 | 6.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.9 | 3.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.9 | 6.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.9 | 10.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.9 | 36.8 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.9 | 3.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.9 | 0.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.9 | 7.0 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.9 | 13.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.9 | 6.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.9 | 0.9 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.9 | 7.8 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.9 | 5.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.9 | 9.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.9 | 8.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.9 | 11.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.9 | 12.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.8 | 5.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.8 | 5.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.8 | 1.7 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.8 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 1.7 | GO:0019081 | viral translation(GO:0019081) |
0.8 | 4.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.8 | 0.8 | GO:0009164 | nucleoside catabolic process(GO:0009164) |
0.8 | 2.5 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.8 | 0.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.8 | 1.7 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.8 | 1.7 | GO:0048793 | pronephros development(GO:0048793) |
0.8 | 1.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 2.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 5.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.8 | 10.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.8 | 4.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 7.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.8 | 5.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.8 | 4.1 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.8 | 4.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.8 | 2.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 4.9 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.8 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.8 | 3.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.8 | 1.6 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.8 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 2.4 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.8 | 1.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.8 | 2.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.8 | 1.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.8 | 0.8 | GO:0015819 | lysine transport(GO:0015819) |
0.8 | 2.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 4.0 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.8 | 1.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 1.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.8 | 2.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.8 | 7.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.8 | 1.6 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.8 | 0.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.8 | 7.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.8 | 0.8 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.8 | 27.4 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.8 | 5.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.8 | 2.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.8 | 3.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.8 | 2.3 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.8 | 16.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.8 | 6.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.8 | 0.8 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.8 | 8.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.8 | 1.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.8 | 3.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.8 | 3.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.8 | 9.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.8 | 4.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.8 | 7.0 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.8 | 4.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 10.8 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.8 | 7.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.8 | 5.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.8 | 1.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.8 | 1.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.8 | 5.4 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.8 | 8.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.8 | 3.8 | GO:0032438 | melanosome organization(GO:0032438) |
0.8 | 4.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.8 | 0.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.8 | 3.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.8 | 3.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.8 | 3.0 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.8 | 0.8 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.8 | 19.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.8 | 9.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.8 | 10.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.8 | 28.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.8 | 0.8 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.8 | 3.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.8 | 0.8 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.8 | 5.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.8 | 0.8 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.8 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.8 | 2.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.7 | 1.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.7 | 10.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.7 | 11.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.7 | 4.5 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.7 | 5.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.7 | 3.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.7 | 11.2 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.7 | 11.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.7 | 3.7 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.7 | 2.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.7 | 1.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.7 | 1.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.7 | 1.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.7 | 0.7 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.7 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.7 | 1.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.7 | 2.2 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.7 | 1.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.7 | 0.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 | 2.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.7 | 2.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.7 | 3.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 5.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.7 | 2.9 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.7 | 18.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.7 | 7.2 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.7 | 0.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.7 | 0.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.7 | 1.4 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.7 | 0.7 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.7 | 0.7 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.7 | 4.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.7 | 7.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 1.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.7 | 7.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.7 | 7.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.7 | 1.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.7 | 1.4 | GO:0050779 | RNA destabilization(GO:0050779) |
0.7 | 0.7 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.7 | 0.7 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.7 | 6.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.7 | 0.7 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.7 | 2.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.7 | 3.4 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.7 | 5.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.7 | 1.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.7 | 2.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.7 | 14.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.7 | 8.1 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.7 | 2.7 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.7 | 2.7 | GO:0071467 | cellular response to pH(GO:0071467) |
0.7 | 1.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.7 | 0.7 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.7 | 0.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.7 | 2.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 1.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.7 | 0.7 | GO:0046490 | negative regulation of cholesterol biosynthetic process(GO:0045541) isopentenyl diphosphate metabolic process(GO:0046490) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 9.9 | GO:0019835 | cytolysis(GO:0019835) |
0.7 | 4.0 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.7 | 1.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.7 | 2.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.7 | 2.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.7 | 2.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.7 | 3.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.7 | 7.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.7 | 2.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.6 | 3.9 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.6 | 2.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 1.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.6 | 2.6 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.6 | 1.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.6 | 7.1 | GO:0019915 | lipid storage(GO:0019915) |
0.6 | 2.6 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.6 | 3.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 5.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.6 | 0.6 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.6 | 2.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.6 | 2.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 1.3 | GO:0070542 | response to fatty acid(GO:0070542) |
0.6 | 0.6 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.6 | 1.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.6 | 18.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.6 | 11.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 1.9 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.6 | 3.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.6 | 2.5 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.6 | 18.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 0.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.6 | 1.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.6 | 5.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 3.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 1.9 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.6 | 6.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.6 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.6 | 1.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.6 | 1.9 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.6 | 3.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 4.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.6 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 15.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.6 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 1.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.6 | 4.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.6 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 2.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 6.6 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.6 | 1.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.6 | 3.6 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.6 | 1.8 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.6 | 3.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.6 | 1.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.6 | 1.8 | GO:0007140 | male meiosis(GO:0007140) |
0.6 | 1.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 0.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.6 | 1.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.6 | 2.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.6 | 0.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.6 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.6 | 2.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.6 | 1.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.6 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 2.9 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.6 | 1.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.6 | 0.6 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.6 | 0.6 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.6 | 2.9 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.6 | 0.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.6 | 1.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.6 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.6 | 0.6 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.6 | 1.2 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.6 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 5.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.6 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.6 | 2.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.6 | 3.4 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.6 | 0.6 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.6 | 1.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.6 | 1.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.6 | 1.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 2.3 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.6 | 0.6 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.6 | 0.6 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.6 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 2.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.6 | 3.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 4.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.6 | 2.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.6 | 2.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.6 | 1.1 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.6 | 2.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.6 | 1.7 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.6 | 1.7 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.6 | 0.6 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.6 | 1.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.6 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.6 | 3.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 1.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.6 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 60.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.5 | 1.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 15.3 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.5 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.5 | 9.8 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.5 | 15.7 | GO:0051168 | nuclear export(GO:0051168) |
0.5 | 1.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 2.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 2.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.5 | 4.8 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.5 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 9.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.5 | 1.1 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.5 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 0.5 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.5 | 1.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.5 | 6.8 | GO:0021591 | ventricular system development(GO:0021591) |
0.5 | 0.5 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.5 | 1.6 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.5 | 2.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.5 | 1.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.5 | 2.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 2.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.5 | 1.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.5 | 4.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.5 | 5.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 1.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.5 | 1.5 | GO:0033280 | response to vitamin D(GO:0033280) |
0.5 | 2.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 5.6 | GO:0060323 | head morphogenesis(GO:0060323) |
0.5 | 1.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 4.5 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.5 | 6.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.5 | 2.5 | GO:0007098 | centrosome cycle(GO:0007098) centrosome duplication(GO:0051298) |
0.5 | 3.0 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.5 | 4.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 10.9 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.5 | 1.5 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 1.5 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.5 | 5.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 2.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.5 | 1.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 3.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.5 | 0.5 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.5 | 3.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.5 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.5 | 0.5 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 17.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.5 | 1.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.5 | 11.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 1.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 8.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.5 | 10.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 45.1 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.5 | 9.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.5 | 0.9 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.5 | 0.5 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.5 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.5 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 21.9 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.5 | 11.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.5 | 4.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.5 | 6.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.5 | 3.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 13.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.4 | 0.4 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.4 | 2.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 3.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 4.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 0.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.4 | 0.4 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.4 | 0.4 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.4 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.9 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 0.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.4 | 0.4 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.4 | 6.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 1.3 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.4 | 3.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 0.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 6.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.4 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 0.9 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.4 | 1.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 0.9 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 0.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.4 | 20.5 | GO:0050817 | coagulation(GO:0050817) |
0.4 | 0.4 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.4 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 3.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 8.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 0.8 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 1.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.4 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.4 | 0.4 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.4 | 10.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 1.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.4 | 4.9 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.4 | 0.8 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.4 | 0.4 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.4 | 3.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 0.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.4 | 0.8 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.4 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 0.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.4 | 2.4 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.4 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.4 | 2.8 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.4 | 0.4 | GO:0008209 | androgen metabolic process(GO:0008209) regulation of testosterone biosynthetic process(GO:2000224) |
0.4 | 2.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 6.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 0.8 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.4 | 1.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 3.5 | GO:0061515 | myeloid cell development(GO:0061515) |
0.4 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 1.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.4 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 1.9 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.4 | 0.4 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.4 | 1.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.4 | 1.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 1.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 0.4 | GO:0009301 | snRNA transcription(GO:0009301) |
0.4 | 0.7 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 0.7 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.4 | GO:0061009 | common bile duct development(GO:0061009) |
0.4 | 0.7 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.4 | 0.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.4 | 0.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.4 | 6.8 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.4 | 3.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.4 | 19.3 | GO:0007059 | chromosome segregation(GO:0007059) |
0.4 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.4 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.4 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.4 | 0.7 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.4 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 0.4 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.4 | 1.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 5.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.4 | 0.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.3 | 1.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.3 | 1.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 1.7 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.3 | 1.4 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.3 | 5.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 0.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 7.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.3 | 0.3 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.3 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 0.7 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 7.1 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.3 | 5.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 2.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 1.0 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.3 | 1.3 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.3 | 3.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 1.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.3 | 1.3 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 1.0 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.3 | 0.3 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.3 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 3.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 3.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 0.6 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 1.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 1.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 1.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 3.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 1.5 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.3 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 2.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.3 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.3 | 0.3 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.3 | 1.8 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 22.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.3 | 5.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.3 | 0.3 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 2.6 | GO:0035904 | aorta development(GO:0035904) |
0.3 | 1.1 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 1.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 11.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 0.6 | GO:0042116 | macrophage activation(GO:0042116) |
0.3 | 0.8 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.3 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.8 | GO:0031929 | TOR signaling(GO:0031929) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 0.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 12.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.3 | 3.8 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.5 | GO:0051701 | interaction with host(GO:0051701) |
0.3 | 0.5 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.3 | 0.5 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 1.5 | GO:0009648 | photoperiodism(GO:0009648) |
0.3 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 3.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 19.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.2 | 1.7 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.2 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.2 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.2 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.7 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.2 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.2 | 0.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.7 | GO:0042516 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.2 | 0.2 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.2 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 5.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0042044 | fluid transport(GO:0042044) |
0.2 | 6.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 1.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.2 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.0 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 1.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 3.3 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.2 | 1.4 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 1.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 8.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 0.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.2 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.7 | GO:0001556 | oocyte maturation(GO:0001556) |
0.2 | 1.2 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.2 | 0.2 | GO:0060795 | cell fate commitment involved in formation of primary germ layer(GO:0060795) |
0.2 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.2 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 4.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 3.2 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 0.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.2 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.1 | 0.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.3 | GO:0019083 | viral transcription(GO:0019083) |
0.1 | 0.1 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 1.4 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 0.3 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 4.4 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0022403 | cell cycle phase(GO:0022403) |
0.1 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0043476 | pigment accumulation(GO:0043476) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 3.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 1.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.2 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 1.3 | GO:0072331 | signal transduction by p53 class mediator(GO:0072331) |
0.1 | 0.2 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.5 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.2 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.1 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.2 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 3.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 13.2 | GO:0048232 | male gamete generation(GO:0048232) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 73.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.1 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.1 | 0.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 1.8 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 5.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.3 | GO:0098732 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.1 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 2.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.2 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 1.8 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
0.0 | 0.0 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.0 | GO:0043489 | RNA stabilization(GO:0043489) |
0.0 | 0.0 | GO:1903707 | negative regulation of hemopoiesis(GO:1903707) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.7 | 68.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
9.8 | 29.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
8.4 | 41.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
8.2 | 24.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
5.9 | 23.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
5.3 | 53.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
5.0 | 19.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
4.8 | 14.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
4.7 | 14.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
4.6 | 23.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
4.6 | 18.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
4.6 | 4.6 | GO:0000791 | euchromatin(GO:0000791) |
4.6 | 23.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
4.6 | 22.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
4.5 | 4.5 | GO:0031523 | Myb complex(GO:0031523) |
4.5 | 31.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
4.4 | 35.6 | GO:0045179 | apical cortex(GO:0045179) |
4.3 | 47.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
4.2 | 12.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
4.0 | 16.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
3.9 | 11.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.9 | 19.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
3.7 | 25.6 | GO:0043219 | lateral loop(GO:0043219) |
3.6 | 10.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.6 | 72.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
3.6 | 14.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
3.4 | 20.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
3.4 | 6.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
3.3 | 46.7 | GO:0031528 | microvillus membrane(GO:0031528) |
3.3 | 13.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
3.3 | 9.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
3.2 | 12.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
3.2 | 12.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.2 | 12.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
3.1 | 9.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
3.1 | 6.3 | GO:0097452 | GAIT complex(GO:0097452) |
3.1 | 6.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
3.0 | 9.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.0 | 12.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.0 | 6.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
3.0 | 14.8 | GO:0031983 | vesicle lumen(GO:0031983) |
2.9 | 26.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
2.9 | 8.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.9 | 2.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
2.9 | 17.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.9 | 20.1 | GO:0030056 | hemidesmosome(GO:0030056) |
2.8 | 8.5 | GO:0097443 | sorting endosome(GO:0097443) |
2.8 | 11.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.8 | 11.2 | GO:0072487 | MSL complex(GO:0072487) |
2.8 | 2.8 | GO:0044327 | dendritic spine head(GO:0044327) |
2.8 | 8.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
2.8 | 8.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.7 | 5.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.7 | 5.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
2.7 | 11.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.7 | 8.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.7 | 85.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.7 | 10.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.7 | 5.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
2.7 | 10.7 | GO:1990130 | Iml1 complex(GO:1990130) |
2.6 | 7.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.6 | 2.6 | GO:0034464 | BBSome(GO:0034464) |
2.6 | 10.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.6 | 2.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
2.5 | 58.3 | GO:0008305 | integrin complex(GO:0008305) |
2.4 | 56.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.3 | 16.3 | GO:0042382 | paraspeckles(GO:0042382) |
2.3 | 7.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.3 | 18.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.3 | 23.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
2.3 | 13.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.3 | 9.2 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.3 | 206.1 | GO:0072562 | blood microparticle(GO:0072562) |
2.3 | 22.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.3 | 2.3 | GO:0042827 | platelet dense granule(GO:0042827) |
2.2 | 6.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.2 | 25.9 | GO:0061702 | inflammasome complex(GO:0061702) |
2.1 | 17.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.1 | 2.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
2.1 | 10.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
2.1 | 236.4 | GO:0005903 | brush border(GO:0005903) |
2.1 | 2.1 | GO:0001739 | sex chromatin(GO:0001739) |
2.1 | 23.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.1 | 23.0 | GO:0035102 | PRC1 complex(GO:0035102) |
2.1 | 8.4 | GO:0043203 | axon hillock(GO:0043203) |
2.1 | 8.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
2.1 | 6.3 | GO:1990423 | RZZ complex(GO:1990423) |
2.1 | 6.2 | GO:0097413 | Lewy body(GO:0097413) |
2.1 | 8.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.0 | 8.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.0 | 6.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.0 | 6.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.0 | 10.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
2.0 | 8.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
2.0 | 7.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
2.0 | 2.0 | GO:0000346 | transcription export complex(GO:0000346) |
2.0 | 7.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.9 | 1.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.9 | 11.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.9 | 13.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.9 | 9.6 | GO:0005638 | lamin filament(GO:0005638) |
1.9 | 5.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.9 | 11.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.9 | 3.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.9 | 7.6 | GO:0071565 | nBAF complex(GO:0071565) |
1.9 | 85.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.9 | 11.4 | GO:0005818 | aster(GO:0005818) |
1.9 | 1.9 | GO:0097422 | tubular endosome(GO:0097422) |
1.9 | 16.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.9 | 13.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.9 | 5.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.8 | 11.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.8 | 12.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.8 | 7.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.8 | 12.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.8 | 5.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.8 | 12.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.8 | 23.3 | GO:0001891 | phagocytic cup(GO:0001891) |
1.8 | 5.4 | GO:0005914 | spot adherens junction(GO:0005914) |
1.8 | 5.3 | GO:0043293 | apoptosome(GO:0043293) |
1.8 | 30.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.8 | 1.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.7 | 12.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.7 | 6.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.7 | 10.4 | GO:0042587 | glycogen granule(GO:0042587) |
1.7 | 3.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.7 | 22.4 | GO:0038201 | TOR complex(GO:0038201) |
1.7 | 6.9 | GO:0016600 | flotillin complex(GO:0016600) |
1.7 | 5.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.7 | 44.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.7 | 32.5 | GO:0045120 | pronucleus(GO:0045120) |
1.7 | 5.1 | GO:0071953 | elastic fiber(GO:0071953) |
1.7 | 47.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.7 | 110.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.7 | 5.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.7 | 5.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.7 | 3.3 | GO:0005579 | membrane attack complex(GO:0005579) |
1.6 | 13.1 | GO:0097470 | ribbon synapse(GO:0097470) |
1.6 | 8.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.6 | 3.3 | GO:0071203 | WASH complex(GO:0071203) |
1.6 | 4.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.6 | 4.9 | GO:0005745 | m-AAA complex(GO:0005745) |
1.6 | 9.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.6 | 6.5 | GO:0000938 | GARP complex(GO:0000938) |
1.6 | 11.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.6 | 30.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.6 | 20.9 | GO:0000974 | Prp19 complex(GO:0000974) |
1.6 | 4.8 | GO:1990635 | proximal dendrite(GO:1990635) |
1.6 | 4.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.6 | 3.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.6 | 4.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.6 | 6.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 20.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.6 | 79.1 | GO:0005811 | lipid particle(GO:0005811) |
1.5 | 13.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 7.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.5 | 24.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.5 | 38.2 | GO:0016592 | mediator complex(GO:0016592) |
1.5 | 16.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.5 | 19.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.5 | 1.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.5 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.5 | 21.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.5 | 7.5 | GO:0005827 | polar microtubule(GO:0005827) |
1.5 | 14.8 | GO:0070852 | cell body fiber(GO:0070852) |
1.5 | 5.9 | GO:0044194 | cytolytic granule(GO:0044194) |
1.5 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.5 | 4.4 | GO:0090544 | BAF-type complex(GO:0090544) |
1.5 | 4.4 | GO:0005712 | chiasma(GO:0005712) |
1.5 | 7.3 | GO:0061617 | MICOS complex(GO:0061617) |
1.5 | 4.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.5 | 1.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.5 | 11.6 | GO:0005876 | spindle microtubule(GO:0005876) |
1.4 | 15.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.4 | 20.3 | GO:0043034 | costamere(GO:0043034) |
1.4 | 7.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.4 | 4.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.4 | 1.4 | GO:0005642 | annulate lamellae(GO:0005642) |
1.4 | 4.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.4 | 8.4 | GO:0031415 | NatA complex(GO:0031415) |
1.4 | 29.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.4 | 4.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.4 | 77.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.4 | 9.7 | GO:0005869 | dynactin complex(GO:0005869) |
1.4 | 20.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.4 | 24.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.4 | 2.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.4 | 2.7 | GO:1990923 | PET complex(GO:1990923) |
1.4 | 5.4 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
1.4 | 10.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.4 | 13.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.4 | 5.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.3 | 29.7 | GO:0034451 | centriolar satellite(GO:0034451) |
1.3 | 2.7 | GO:0032280 | symmetric synapse(GO:0032280) |
1.3 | 4.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.3 | 9.4 | GO:0005688 | U6 snRNP(GO:0005688) |
1.3 | 57.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.3 | 10.6 | GO:0042581 | specific granule(GO:0042581) |
1.3 | 8.0 | GO:0031512 | motile primary cilium(GO:0031512) |
1.3 | 5.3 | GO:1990246 | uniplex complex(GO:1990246) |
1.3 | 2.6 | GO:0071439 | clathrin complex(GO:0071439) |
1.3 | 7.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.3 | 2.6 | GO:0000805 | X chromosome(GO:0000805) |
1.3 | 15.7 | GO:0016363 | nuclear matrix(GO:0016363) |
1.3 | 13.0 | GO:0031430 | M band(GO:0031430) |
1.3 | 5.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.3 | 6.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.3 | 7.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.3 | 11.7 | GO:0010369 | chromocenter(GO:0010369) |
1.3 | 51.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.3 | 5.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.3 | 6.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.3 | 54.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.3 | 39.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.3 | 6.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.3 | 6.3 | GO:0033503 | HULC complex(GO:0033503) |
1.3 | 8.8 | GO:0032797 | SMN complex(GO:0032797) |
1.2 | 3.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.2 | 11.2 | GO:0097542 | ciliary tip(GO:0097542) |
1.2 | 85.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.2 | 8.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.2 | 135.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.2 | 4.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.2 | 7.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.2 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
1.2 | 4.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.2 | 6.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.2 | 2.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.2 | 6.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.2 | 7.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.2 | 4.8 | GO:0098536 | deuterosome(GO:0098536) |
1.2 | 190.5 | GO:0031965 | nuclear membrane(GO:0031965) |
1.2 | 3.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.2 | 4.8 | GO:0000812 | Swr1 complex(GO:0000812) |
1.2 | 44.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.2 | 17.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.2 | 57.4 | GO:0000922 | spindle pole(GO:0000922) |
1.2 | 3.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.2 | 21.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.2 | 5.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.2 | 14.0 | GO:0031672 | A band(GO:0031672) |
1.2 | 5.8 | GO:0030914 | STAGA complex(GO:0030914) |
1.2 | 9.3 | GO:0031143 | pseudopodium(GO:0031143) |
1.1 | 4.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.1 | 13.7 | GO:0036038 | MKS complex(GO:0036038) |
1.1 | 1.1 | GO:0070545 | PeBoW complex(GO:0070545) |
1.1 | 4.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.1 | 5.7 | GO:0001650 | fibrillar center(GO:0001650) |
1.1 | 23.7 | GO:0001772 | immunological synapse(GO:0001772) |
1.1 | 10.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.1 | 12.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.1 | 85.3 | GO:0030496 | midbody(GO:0030496) |
1.1 | 2.2 | GO:0030689 | Noc complex(GO:0030689) |
1.1 | 14.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.1 | 15.7 | GO:0000145 | exocyst(GO:0000145) |
1.1 | 14.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.1 | 3.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.1 | 2.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.1 | 3.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.1 | 1.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
1.1 | 223.9 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 2.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.1 | 4.3 | GO:0035339 | SPOTS complex(GO:0035339) |
1.1 | 9.7 | GO:0043196 | varicosity(GO:0043196) |
1.1 | 40.9 | GO:0042641 | actomyosin(GO:0042641) |
1.1 | 1.1 | GO:0008278 | cohesin complex(GO:0008278) |
1.1 | 13.8 | GO:0030904 | retromer complex(GO:0030904) |
1.1 | 3.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.1 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
1.1 | 2.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.0 | 35.6 | GO:0005776 | autophagosome(GO:0005776) |
1.0 | 4.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.0 | 11.3 | GO:0005771 | multivesicular body(GO:0005771) |
1.0 | 24.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
1.0 | 4.0 | GO:0098798 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) mitochondrial protein complex(GO:0098798) |
1.0 | 26.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.0 | 5.0 | GO:0000796 | condensin complex(GO:0000796) |
1.0 | 1.0 | GO:1903349 | omegasome membrane(GO:1903349) |
1.0 | 27.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
1.0 | 3.0 | GO:0034709 | methylosome(GO:0034709) |
1.0 | 2.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.0 | 2.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.0 | 2.9 | GO:0097440 | apical dendrite(GO:0097440) |
1.0 | 2.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.0 | 3.9 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.0 | 3.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.0 | 8.6 | GO:0002102 | podosome(GO:0002102) |
1.0 | 66.5 | GO:0005581 | collagen trimer(GO:0005581) |
1.0 | 17.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.9 | 6.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.9 | 3.7 | GO:0001652 | granular component(GO:0001652) |
0.9 | 5.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.9 | 5.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.9 | 14.8 | GO:0016459 | myosin complex(GO:0016459) |
0.9 | 2.8 | GO:0032009 | early phagosome(GO:0032009) |
0.9 | 11.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.9 | 3.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 4.6 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.9 | 7.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 4.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.9 | 11.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.9 | 8.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.9 | 2.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.9 | 10.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.9 | 34.5 | GO:0000776 | kinetochore(GO:0000776) |
0.9 | 4.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.9 | 1.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.9 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.9 | 27.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.9 | 8.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.9 | 2.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.9 | 19.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.9 | 40.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.9 | 3.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 12.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 4.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.8 | 6.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.8 | 3.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.8 | 13.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.8 | 1488.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.8 | 12.1 | GO:0005844 | polysome(GO:0005844) |
0.8 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.8 | 7.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.8 | 107.6 | GO:0005694 | chromosome(GO:0005694) |
0.8 | 7.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.8 | 2.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.8 | 6.2 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 12.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.8 | 50.4 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.7 | 174.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.7 | 5.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.7 | 2.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.7 | 3.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 11.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.7 | 5.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 8.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.7 | 1.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 6.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.7 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 4.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.7 | 712.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.7 | 12.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.7 | 124.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.7 | 0.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.7 | 21.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.7 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 2.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 2.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.7 | 16.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.7 | 5.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 0.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.7 | 3.3 | GO:0016235 | aggresome(GO:0016235) |
0.7 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.7 | 1.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.7 | 1.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 3.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.6 | 11.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.6 | 1.3 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.6 | 1.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.6 | 1.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 132.5 | GO:0005730 | nucleolus(GO:0005730) |
0.6 | 37.8 | GO:0031514 | motile cilium(GO:0031514) |
0.6 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 3.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.6 | 1.1 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.5 | 1.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 20.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 30.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.5 | 1.6 | GO:0000243 | commitment complex(GO:0000243) |
0.5 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 2.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 8.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 268.9 | GO:0005829 | cytosol(GO:0005829) |
0.5 | 3.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 0.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.5 | 2.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 1.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 1.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.5 | 10.0 | GO:0045095 | keratin filament(GO:0045095) |
0.5 | 1.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.5 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.5 | 0.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.5 | 1.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 16.4 | GO:0030141 | secretory granule(GO:0030141) |
0.5 | 243.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.5 | 8.6 | GO:0005938 | cell cortex(GO:0005938) |
0.4 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 0.8 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 242.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.4 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 6.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 0.4 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 2.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.4 | 50.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 13.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.4 | 0.7 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 2.7 | GO:0036379 | myofilament(GO:0036379) |
0.3 | 6.7 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.3 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 8.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 8.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 1.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 32.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 2.2 | GO:0005901 | caveola(GO:0005901) |
0.2 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 0.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 0.2 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 3.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 12.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 10.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 18.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 1.3 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 84.1 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 3.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 54.9 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.6 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 86.7 | GO:0005634 | nucleus(GO:0005634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.7 | 54.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
12.5 | 37.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
11.6 | 34.8 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
11.0 | 32.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
10.7 | 21.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
9.0 | 27.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
8.7 | 60.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
8.1 | 32.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
7.8 | 31.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
7.7 | 30.8 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
7.6 | 30.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
6.9 | 34.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
6.5 | 19.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
6.4 | 12.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
6.3 | 25.3 | GO:0009374 | biotin binding(GO:0009374) |
6.3 | 18.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
6.3 | 18.8 | GO:0019862 | IgA binding(GO:0019862) |
6.2 | 37.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
6.1 | 18.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
6.0 | 23.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
5.9 | 17.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
5.9 | 17.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
5.9 | 23.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
5.8 | 17.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
5.7 | 34.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
5.7 | 17.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
5.6 | 5.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
5.6 | 16.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
5.5 | 22.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
5.5 | 16.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
5.3 | 10.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
5.2 | 20.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
5.2 | 15.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
5.1 | 15.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
5.1 | 15.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
5.0 | 15.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
5.0 | 25.0 | GO:0070061 | fructose binding(GO:0070061) |
5.0 | 14.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.9 | 14.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
4.8 | 43.6 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
4.7 | 14.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
4.6 | 18.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
4.5 | 18.2 | GO:0005534 | galactose binding(GO:0005534) |
4.5 | 13.5 | GO:0050692 | DBD domain binding(GO:0050692) |
4.5 | 36.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
4.5 | 13.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
4.5 | 31.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
4.5 | 17.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
4.5 | 4.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
4.4 | 13.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
4.4 | 26.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
4.4 | 13.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
4.4 | 13.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
4.4 | 35.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
4.4 | 17.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
4.4 | 17.5 | GO:0015232 | heme transporter activity(GO:0015232) |
4.3 | 13.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
4.2 | 21.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
4.2 | 54.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
4.2 | 16.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.2 | 25.0 | GO:0008199 | ferric iron binding(GO:0008199) |
4.1 | 20.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
4.1 | 12.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
4.0 | 16.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
4.0 | 11.9 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
4.0 | 15.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.8 | 7.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
3.8 | 19.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
3.8 | 11.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
3.7 | 11.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
3.7 | 7.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
3.7 | 26.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
3.7 | 48.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
3.7 | 3.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
3.7 | 18.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
3.6 | 3.6 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
3.6 | 10.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
3.6 | 10.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
3.6 | 25.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.6 | 18.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
3.6 | 7.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
3.6 | 7.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
3.5 | 7.1 | GO:0015928 | fucosidase activity(GO:0015928) |
3.5 | 52.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
3.5 | 38.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
3.5 | 20.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
3.4 | 13.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
3.4 | 10.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
3.4 | 13.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.4 | 13.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
3.4 | 16.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
3.4 | 10.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
3.4 | 10.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
3.4 | 10.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
3.3 | 10.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.3 | 9.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.3 | 9.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.3 | 22.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
3.2 | 6.4 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
3.2 | 12.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
3.2 | 9.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.2 | 19.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.2 | 38.1 | GO:0044548 | S100 protein binding(GO:0044548) |
3.1 | 15.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
3.1 | 40.8 | GO:0015643 | toxic substance binding(GO:0015643) |
3.1 | 9.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.1 | 12.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
3.1 | 12.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
3.1 | 18.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
3.1 | 9.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
3.1 | 6.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
3.1 | 46.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
3.1 | 18.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
3.0 | 12.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
3.0 | 14.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
3.0 | 17.9 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
3.0 | 23.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
3.0 | 8.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.9 | 11.8 | GO:0045340 | mercury ion binding(GO:0045340) |
2.9 | 11.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.9 | 14.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.9 | 11.7 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
2.9 | 8.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.9 | 17.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
2.9 | 2.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
2.9 | 2.9 | GO:0036033 | mediator complex binding(GO:0036033) |
2.9 | 11.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
2.9 | 20.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.9 | 2.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.9 | 54.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
2.8 | 19.9 | GO:0046790 | virion binding(GO:0046790) |
2.8 | 2.8 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
2.8 | 11.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
2.8 | 25.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.8 | 64.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.8 | 11.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.8 | 5.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
2.8 | 5.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
2.8 | 8.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.8 | 16.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.8 | 16.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.8 | 25.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.8 | 11.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.8 | 38.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
2.8 | 8.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.8 | 8.3 | GO:0032041 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
2.7 | 8.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.7 | 2.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.7 | 32.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.7 | 10.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.7 | 24.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
2.7 | 13.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.7 | 8.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.7 | 2.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
2.7 | 18.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
2.7 | 2.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
2.7 | 10.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.7 | 26.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
2.6 | 7.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.6 | 25.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.6 | 10.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.6 | 7.7 | GO:0097016 | L27 domain binding(GO:0097016) |
2.6 | 7.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.6 | 25.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
2.6 | 30.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.5 | 10.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.5 | 7.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
2.5 | 7.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.5 | 7.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
2.5 | 7.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
2.5 | 2.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.5 | 12.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.5 | 12.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.5 | 7.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.5 | 19.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.5 | 2.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.4 | 31.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.4 | 7.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.4 | 31.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.4 | 38.7 | GO:0008143 | poly(A) binding(GO:0008143) |
2.4 | 12.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.4 | 7.2 | GO:0008142 | oxysterol binding(GO:0008142) |
2.4 | 7.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
2.4 | 4.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.4 | 14.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.4 | 2.4 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
2.4 | 7.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.4 | 14.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.4 | 19.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
2.4 | 9.5 | GO:0051425 | PTB domain binding(GO:0051425) |
2.4 | 7.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.4 | 4.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
2.4 | 21.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.4 | 7.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
2.4 | 11.8 | GO:0034452 | dynactin binding(GO:0034452) |
2.4 | 7.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
2.3 | 21.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.3 | 11.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.3 | 9.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.3 | 4.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
2.3 | 6.9 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
2.3 | 16.1 | GO:0000150 | recombinase activity(GO:0000150) |
2.3 | 9.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.3 | 4.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.3 | 2.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
2.3 | 11.4 | GO:0008430 | selenium binding(GO:0008430) |
2.3 | 34.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.3 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.3 | 20.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
2.3 | 6.8 | GO:0031491 | nucleosome binding(GO:0031491) |
2.3 | 2.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.3 | 36.2 | GO:0008483 | transaminase activity(GO:0008483) |
2.3 | 13.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
2.2 | 11.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
2.2 | 31.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.2 | 19.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
2.2 | 11.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
2.2 | 17.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.2 | 17.5 | GO:0001846 | opsonin binding(GO:0001846) |
2.2 | 13.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.2 | 4.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.2 | 19.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.2 | 8.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
2.2 | 10.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.1 | 36.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
2.1 | 6.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.1 | 6.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.1 | 10.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.1 | 8.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.1 | 12.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.1 | 6.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.1 | 8.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
2.1 | 6.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.1 | 24.9 | GO:0017166 | vinculin binding(GO:0017166) |
2.1 | 8.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.1 | 6.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.0 | 8.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
2.0 | 6.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.0 | 10.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
2.0 | 20.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.0 | 8.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.0 | 14.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
2.0 | 16.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
2.0 | 22.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.0 | 8.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.0 | 4.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
2.0 | 5.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.0 | 2.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.0 | 7.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.0 | 5.9 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.9 | 9.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.9 | 5.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.9 | 9.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.9 | 1.9 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
1.9 | 3.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.9 | 7.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.9 | 36.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.9 | 20.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.9 | 13.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.9 | 13.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.9 | 5.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.9 | 54.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.9 | 22.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.9 | 13.1 | GO:0008494 | translation activator activity(GO:0008494) |
1.9 | 5.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.9 | 14.9 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
1.9 | 5.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.8 | 16.6 | GO:0001848 | complement binding(GO:0001848) |
1.8 | 7.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.8 | 25.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.8 | 7.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.8 | 5.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.8 | 14.6 | GO:0039706 | co-receptor binding(GO:0039706) |
1.8 | 5.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.8 | 14.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.8 | 9.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.8 | 1.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.8 | 10.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.8 | 16.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.8 | 30.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.8 | 52.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.8 | 1.8 | GO:0048030 | disaccharide binding(GO:0048030) |
1.8 | 34.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.8 | 7.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.8 | 5.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.8 | 5.3 | GO:0019961 | interferon binding(GO:0019961) |
1.8 | 5.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.8 | 7.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.8 | 5.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.8 | 10.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.8 | 23.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.8 | 3.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.8 | 14.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.8 | 5.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.8 | 3.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.7 | 5.2 | GO:1990188 | euchromatin binding(GO:1990188) |
1.7 | 1.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.7 | 5.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.7 | 3.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.7 | 10.3 | GO:0019841 | retinol binding(GO:0019841) |
1.7 | 12.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.7 | 8.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.7 | 10.3 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
1.7 | 1.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.7 | 1.7 | GO:0045182 | translation regulator activity(GO:0045182) |
1.7 | 3.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.7 | 3.4 | GO:0032190 | acrosin binding(GO:0032190) |
1.7 | 46.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.7 | 5.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.7 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.7 | 6.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.7 | 8.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.6 | 11.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.6 | 1.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.6 | 4.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.6 | 4.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.6 | 6.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.6 | 11.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.6 | 3.3 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
1.6 | 8.1 | GO:0071253 | connexin binding(GO:0071253) |
1.6 | 35.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.6 | 6.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.6 | 6.5 | GO:0031419 | cobalamin binding(GO:0031419) |
1.6 | 6.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.6 | 6.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.6 | 19.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
1.6 | 3.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.6 | 14.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.6 | 22.4 | GO:0005521 | lamin binding(GO:0005521) |
1.6 | 6.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.6 | 9.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.6 | 22.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.6 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.6 | 11.1 | GO:0050700 | CARD domain binding(GO:0050700) |
1.6 | 6.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.6 | 1.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.6 | 1.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.6 | 4.7 | GO:0004064 | arylesterase activity(GO:0004064) |
1.6 | 17.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.6 | 4.7 | GO:0038100 | nodal binding(GO:0038100) |
1.6 | 7.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.5 | 4.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.5 | 7.7 | GO:0031013 | troponin I binding(GO:0031013) |
1.5 | 3.1 | GO:0030984 | kininogen binding(GO:0030984) |
1.5 | 13.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.5 | 9.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.5 | 7.7 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
1.5 | 6.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.5 | 15.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.5 | 7.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.5 | 10.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.5 | 15.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.5 | 6.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.5 | 4.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.5 | 24.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.5 | 1.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.5 | 6.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.5 | 1.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.5 | 47.1 | GO:0005507 | copper ion binding(GO:0005507) |
1.5 | 4.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.5 | 46.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.5 | 3.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.5 | 3.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.5 | 14.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.5 | 16.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.5 | 7.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.5 | 17.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.5 | 2.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.5 | 5.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.5 | 17.4 | GO:0045502 | dynein binding(GO:0045502) |
1.5 | 11.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
1.4 | 4.3 | GO:0051379 | epinephrine binding(GO:0051379) |
1.4 | 4.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.4 | 4.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.4 | 4.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.4 | 12.9 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
1.4 | 4.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.4 | 10.0 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.4 | 41.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.4 | 44.3 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
1.4 | 17.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.4 | 58.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
1.4 | 4.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.4 | 8.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.4 | 7.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.4 | 7.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.4 | 4.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.4 | 2.8 | GO:0035877 | death effector domain binding(GO:0035877) |
1.4 | 2.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.4 | 5.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.4 | 4.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.4 | 4.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.4 | 12.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.4 | 4.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.4 | 9.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.4 | 8.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.4 | 5.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.4 | 11.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.4 | 5.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.4 | 23.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.4 | 6.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.4 | 13.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.4 | 15.0 | GO:0043274 | phospholipase binding(GO:0043274) |
1.4 | 5.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.4 | 4.1 | GO:0038132 | neuregulin binding(GO:0038132) |
1.4 | 1.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.4 | 14.9 | GO:0005542 | folic acid binding(GO:0005542) |
1.3 | 4.0 | GO:0001032 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.3 | 8.1 | GO:0043495 | protein anchor(GO:0043495) |
1.3 | 4.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.3 | 6.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.3 | 43.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.3 | 2.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.3 | 15.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.3 | 137.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.3 | 10.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.3 | 6.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.3 | 9.1 | GO:0031996 | thioesterase binding(GO:0031996) |
1.3 | 5.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.3 | 7.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.3 | 5.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.3 | 49.4 | GO:0005518 | collagen binding(GO:0005518) |
1.3 | 16.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.3 | 26.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.3 | 3.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.3 | 6.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.3 | 2.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.3 | 38.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.3 | 29.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.3 | 31.0 | GO:0043236 | laminin binding(GO:0043236) |
1.3 | 1.3 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
1.3 | 3.9 | GO:0034618 | arginine binding(GO:0034618) |
1.3 | 46.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.3 | 18.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.3 | 6.4 | GO:0034046 | poly(G) binding(GO:0034046) |
1.3 | 32.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.3 | 3.8 | GO:0055100 | adiponectin binding(GO:0055100) |
1.3 | 2.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.3 | 11.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.3 | 1.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.3 | 3.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.3 | 37.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.3 | 6.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.3 | 5.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.2 | 12.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.2 | 12.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.2 | 33.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
1.2 | 34.4 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.2 | 6.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.2 | 20.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
1.2 | 2.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.2 | 7.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.2 | 9.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.2 | 115.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.2 | 8.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.2 | 14.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.2 | 4.7 | GO:0005499 | vitamin D binding(GO:0005499) |
1.2 | 1.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.2 | 33.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.2 | 7.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.2 | 9.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.2 | 28.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.2 | 14.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.2 | 2.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.2 | 7.0 | GO:0035326 | enhancer binding(GO:0035326) |
1.2 | 13.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.2 | 3.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.2 | 10.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.2 | 2.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.1 | 3.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.1 | 2.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.1 | 12.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.1 | 2.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.1 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.1 | 11.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.1 | 5.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 4.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.1 | 3.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.1 | 4.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.1 | 42.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.1 | 2.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
1.1 | 3.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.1 | 3.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.1 | 6.6 | GO:0019213 | deacetylase activity(GO:0019213) |
1.1 | 3.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.1 | 4.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.1 | 6.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.1 | 4.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.1 | 3.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.1 | 3.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.1 | 3.3 | GO:0031014 | troponin T binding(GO:0031014) |
1.1 | 13.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.1 | 31.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.1 | 3.2 | GO:2001069 | glycogen binding(GO:2001069) |
1.1 | 3.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.0 | 3.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
1.0 | 183.9 | GO:0070736 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
1.0 | 3.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.0 | 16.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.0 | 2.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.0 | 3.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.0 | 15.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.0 | 1.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.0 | 5.1 | GO:0034580 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
1.0 | 1.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.0 | 4.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.0 | 3.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.0 | 4.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.0 | 2.0 | GO:0016015 | morphogen activity(GO:0016015) |
1.0 | 7.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.0 | 14.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.0 | 3.0 | GO:0043515 | kinetochore binding(GO:0043515) |
1.0 | 3.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.0 | 4.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.0 | 1.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.0 | 3.0 | GO:0043426 | MRF binding(GO:0043426) |
1.0 | 2.0 | GO:0019808 | polyamine binding(GO:0019808) |
1.0 | 9.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.0 | 5.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.0 | 2.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.0 | 8.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.0 | 3.0 | GO:0004359 | glutaminase activity(GO:0004359) |
1.0 | 6.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.0 | 12.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.0 | 5.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.0 | 1.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
1.0 | 3.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.0 | 8.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.0 | 10.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.0 | 10.7 | GO:0009975 | cyclase activity(GO:0009975) |
1.0 | 2.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.0 | 2.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.0 | 16.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.0 | 6.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.0 | 3.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.0 | 5.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.0 | 23.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.0 | 5.7 | GO:0050733 | RS domain binding(GO:0050733) |
1.0 | 2.9 | GO:0019002 | GMP binding(GO:0019002) |
1.0 | 5.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.9 | 1.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.9 | 2.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 3.8 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.9 | 2.8 | GO:0043559 | insulin binding(GO:0043559) |
0.9 | 20.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.9 | 8.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.9 | 3.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.9 | 8.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.9 | 12.0 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.9 | 3.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.9 | 63.8 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.9 | 4.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.9 | 1.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 29.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.9 | 6.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.9 | 8.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.9 | 1.8 | GO:0051184 | cofactor transporter activity(GO:0051184) coenzyme transporter activity(GO:0051185) |
0.9 | 6.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.9 | 6.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 11.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.9 | 19.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.9 | 5.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.9 | 5.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.9 | 0.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.9 | 4.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.9 | 22.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.9 | 2.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.9 | 2.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.9 | 1.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.9 | 2.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.9 | 5.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.8 | 23.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.8 | 16.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.8 | 4.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.8 | 2.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 2.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 9.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.8 | 9.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.8 | 3.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 2.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.8 | 6.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.8 | 2.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.8 | 9.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 8.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.8 | 3.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.8 | 4.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.8 | 4.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.8 | 3.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.8 | 16.9 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.8 | 9.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.8 | 4.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.8 | 0.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.8 | 20.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.8 | 4.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.8 | 33.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.8 | 3.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.8 | 6.3 | GO:0016878 | succinate-CoA ligase activity(GO:0004774) CoA-ligase activity(GO:0016405) acid-thiol ligase activity(GO:0016878) |
0.8 | 0.8 | GO:0047391 | type 2A serotonin receptor binding(GO:0031826) alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.8 | 2.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.8 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.8 | 3.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.8 | 1.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.8 | 2.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 2.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.8 | 2.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.8 | 13.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 25.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.8 | 2.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 22.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.8 | 5.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 6.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.8 | 1.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.8 | 126.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.7 | 2.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.7 | 26.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.7 | 23.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.7 | 3.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.7 | 5.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 6.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.7 | 2.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.7 | 1.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.7 | 0.7 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.7 | 2.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.7 | 17.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.7 | 2.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.7 | 7.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 2.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 18.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 102.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.7 | 4.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.7 | 1.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 10.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.7 | 2.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 0.7 | GO:0097617 | annealing activity(GO:0097617) |
0.7 | 41.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.7 | 2.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 1.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.7 | 11.3 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.7 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 0.7 | GO:0005119 | smoothened binding(GO:0005119) |
0.7 | 6.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.7 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 37.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.7 | 4.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.7 | 5.9 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 2.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 1.9 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.6 | 10.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 5.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.6 | 5.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.6 | 5.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.6 | 13.2 | GO:0004519 | endonuclease activity(GO:0004519) |
0.6 | 3.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 3.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.6 | 10.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.6 | 8.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 2.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 1.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 1.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) translation release factor activity, codon specific(GO:0016149) |
0.6 | 3.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.6 | 3.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 3.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 1.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 3.0 | GO:0010181 | FMN binding(GO:0010181) |
0.6 | 50.2 | GO:0051020 | GTPase binding(GO:0051020) |
0.6 | 1.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.6 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 1.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.6 | 5.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.6 | 1.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.6 | 41.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.6 | 3.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 1.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.6 | 2.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.6 | 0.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.6 | 1.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 26.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.6 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 1.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 2.9 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.6 | 2.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.6 | 2.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 1.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 5.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 2.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 0.6 | GO:0015926 | glucosidase activity(GO:0015926) |
0.6 | 3.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.6 | 21.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.6 | 3.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 11.5 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 2.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 1.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 1.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 34.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.5 | 24.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 2.6 | GO:0016886 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 3.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 2.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 2.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.5 | 11.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 1.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 7.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.5 | 3.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.5 | 3.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.5 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 1.5 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.5 | 5.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.5 | 0.5 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.5 | 4.1 | GO:0046977 | TAP binding(GO:0046977) |
0.5 | 89.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 6.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.5 | 3.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 8.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.5 | 1.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.5 | 13.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.5 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.5 | 2.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 2.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 1.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 8.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.5 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 3.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 1.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 18.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 1.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.5 | 13.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 0.5 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.5 | 3.7 | GO:0070990 | snRNP binding(GO:0070990) |
0.5 | 1.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.5 | 0.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 3.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 27.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 1.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 3.6 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.4 | 2.2 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 0.9 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 2.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 8.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 1.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 10.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.4 | 6.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 15.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 0.4 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.4 | 9.6 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.4 | 27.5 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 1.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 6.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.4 | 1.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.4 | 6.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 6.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 2.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 17.5 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 10.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 1.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 2.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 3.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.4 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 3.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 19.7 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 24.7 | GO:0016791 | phosphatase activity(GO:0016791) |
0.3 | 2.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 2.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 2.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 94.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 0.3 | GO:0034928 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 1.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 4.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 5.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 1.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 1.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 11.9 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 6.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 3.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 12.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 60.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.3 | 22.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.3 | 0.6 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.3 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.3 | 30.9 | GO:0005525 | GTP binding(GO:0005525) |
0.3 | 31.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 132.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.3 | 1.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 3.4 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 22.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 3.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 5.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 7.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 1.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.2 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.2 | 0.9 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 4.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.2 | 1.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.2 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.2 | 0.6 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 6.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 1.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.2 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.2 | 6.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 3.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 1.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 2.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.2 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 4.2 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 7.2 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 10.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 4.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 1.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 123.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 85.4 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.7 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 2.0 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.9 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 7.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.4 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.2 | GO:0051287 | NAD binding(GO:0051287) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 4.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
4.4 | 192.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
3.8 | 3.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
3.7 | 7.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
3.5 | 34.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
3.4 | 27.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.2 | 82.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
3.1 | 31.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
3.0 | 36.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
3.0 | 39.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
3.0 | 83.1 | PID IGF1 PATHWAY | IGF1 pathway |
3.0 | 56.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.9 | 99.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.9 | 28.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.9 | 142.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.8 | 5.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
2.8 | 47.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.7 | 139.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
2.5 | 27.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.5 | 5.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
2.5 | 19.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.4 | 2.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.3 | 29.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.3 | 68.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
2.3 | 45.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
2.2 | 66.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
2.2 | 41.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.2 | 8.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
2.2 | 19.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.1 | 8.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.1 | 47.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.0 | 18.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
2.0 | 44.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.0 | 15.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.0 | 106.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.0 | 17.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.9 | 40.8 | PID BARD1 PATHWAY | BARD1 signaling events |
1.9 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.9 | 52.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.9 | 7.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.8 | 9.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.8 | 50.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.7 | 19.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.7 | 6.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.7 | 40.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.7 | 6.8 | PID EPO PATHWAY | EPO signaling pathway |
1.6 | 16.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.6 | 20.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.6 | 28.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.6 | 15.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.5 | 54.2 | PID P73PATHWAY | p73 transcription factor network |
1.5 | 15.3 | PID IFNG PATHWAY | IFN-gamma pathway |
1.5 | 19.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.5 | 12.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.5 | 13.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.5 | 14.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.5 | 5.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.4 | 24.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.4 | 17.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.4 | 22.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.4 | 29.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.4 | 8.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.4 | 41.8 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 6.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.3 | 35.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.2 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.2 | 38.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.2 | 60.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.2 | 9.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.2 | 9.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.2 | 17.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.2 | 23.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.2 | 25.5 | PID ARF6 PATHWAY | Arf6 signaling events |
1.2 | 18.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.2 | 5.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.2 | 34.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.1 | 37.8 | PID PLK1 PATHWAY | PLK1 signaling events |
1.1 | 33.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.1 | 63.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.1 | 7.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.1 | 23.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.1 | 16.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.1 | 6.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.1 | 28.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.1 | 45.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.1 | 5.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.1 | 26.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.0 | 10.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.0 | 4.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.0 | 11.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 21.0 | PID E2F PATHWAY | E2F transcription factor network |
0.9 | 8.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.9 | 3.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.9 | 4.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.9 | 5.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 4.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.9 | 2.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.8 | 4.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.8 | 5.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.8 | 4.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 3.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 8.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.8 | 3.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 13.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.7 | 9.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 10.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.7 | 10.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 13.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.7 | 4.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.7 | 5.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.6 | 20.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 1.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 12.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 6.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 4.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.6 | 2.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 5.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.6 | 16.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 4.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.6 | 3.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 9.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 5.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 4.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 9.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 7.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 9.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 9.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 8.5 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 1.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 9.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 12.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.4 | 3.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 2.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 74.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 3.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 2.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 2.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 5.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 3.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 2.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 3.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 2.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 40.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 55.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.1 | 15.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 55.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
5.6 | 89.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
5.4 | 70.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
5.2 | 5.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
4.0 | 36.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
4.0 | 43.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
3.9 | 7.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
3.8 | 61.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
3.8 | 30.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.6 | 36.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.6 | 18.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.5 | 48.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.4 | 30.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
3.4 | 27.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
3.4 | 37.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
3.4 | 57.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
3.3 | 10.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
3.3 | 33.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
3.2 | 58.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
3.2 | 31.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
3.0 | 91.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
3.0 | 48.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
3.0 | 65.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
3.0 | 32.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.9 | 26.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
2.9 | 14.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.9 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
2.9 | 29.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.9 | 11.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.9 | 17.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
2.8 | 67.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.8 | 33.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.8 | 13.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
2.8 | 11.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.7 | 29.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
2.7 | 26.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.6 | 26.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.6 | 5.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
2.5 | 2.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
2.5 | 69.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.5 | 59.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.4 | 36.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.4 | 30.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.4 | 11.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.3 | 63.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.3 | 21.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.3 | 18.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.3 | 23.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.3 | 6.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.3 | 27.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
2.2 | 24.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.2 | 8.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
2.2 | 21.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.2 | 102.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.1 | 2.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
2.1 | 91.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.1 | 19.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
2.1 | 26.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.1 | 18.6 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
2.1 | 51.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.1 | 6.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
2.0 | 12.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.0 | 52.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
2.0 | 2.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.0 | 4.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
2.0 | 7.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
2.0 | 19.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
2.0 | 13.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.0 | 43.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.9 | 7.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.9 | 38.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.9 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.9 | 1.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.9 | 18.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.8 | 27.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.8 | 14.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.8 | 25.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
1.8 | 14.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.8 | 27.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.8 | 18.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.8 | 1.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.8 | 10.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.7 | 22.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.7 | 5.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
1.7 | 10.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.7 | 42.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.7 | 5.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.7 | 15.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.6 | 29.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.6 | 30.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.6 | 4.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.6 | 127.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.6 | 17.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.6 | 15.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.6 | 23.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.6 | 15.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.6 | 17.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.5 | 24.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.5 | 9.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.5 | 10.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.5 | 12.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.5 | 13.5 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
1.5 | 13.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.5 | 221.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.4 | 1.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.4 | 36.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.4 | 10.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.4 | 14.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.4 | 39.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.4 | 18.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.4 | 11.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.4 | 30.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.4 | 13.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.3 | 24.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.3 | 5.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.3 | 6.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.3 | 5.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.3 | 18.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.3 | 3.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.3 | 11.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.3 | 77.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.3 | 52.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.3 | 3.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.3 | 14.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.3 | 42.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
1.3 | 17.8 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.3 | 11.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.3 | 32.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.3 | 17.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.2 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.2 | 11.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.2 | 2.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.2 | 24.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.2 | 10.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.2 | 51.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
1.2 | 1.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.2 | 5.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.2 | 3.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.2 | 10.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.2 | 9.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.1 | 26.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
1.1 | 4.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.1 | 15.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.1 | 7.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.1 | 45.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.1 | 10.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.1 | 13.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.1 | 79.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.1 | 4.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
1.1 | 6.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.1 | 9.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.1 | 12.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.1 | 11.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.0 | 9.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.0 | 8.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.0 | 15.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.0 | 25.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.0 | 13.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.9 | 10.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 2.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.9 | 21.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.9 | 19.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.9 | 3.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.9 | 11.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.9 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.9 | 14.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.9 | 36.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.9 | 20.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.9 | 3.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.9 | 11.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.9 | 6.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 13.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.8 | 6.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.8 | 13.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 23.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.8 | 22.7 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.8 | 13.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.8 | 90.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.8 | 1.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.8 | 2.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.8 | 3.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 9.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.8 | 8.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.8 | 19.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 11.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.8 | 14.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.7 | 12.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.7 | 1.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.7 | 8.8 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.7 | 10.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 7.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 10.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 7.7 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.7 | 15.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.7 | 6.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.7 | 2.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.7 | 0.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.7 | 4.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.7 | 5.9 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.7 | 2.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.6 | 2.6 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.6 | 55.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.6 | 55.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 3.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 9.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.6 | 4.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 2.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 34.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 7.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 4.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 11.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.6 | 11.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 3.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 1.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 1.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.6 | 7.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.5 | 2.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 7.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 0.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.5 | 16.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.5 | 0.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.5 | 8.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 3.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 7.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 9.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 3.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 2.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 16.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 20.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 5.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 6.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.4 | 10.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 6.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 5.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 11.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 3.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.3 | 3.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 7.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 8.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 5.1 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.3 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.2 | 4.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 1.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 1.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 1.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 3.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 6.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |